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1 ZUSAMMENFASSUNG  
 
Posttranskriptionelle Mechanismen tragen zu schnellen durch Entzündungs-/Stress-
Stimuli induzierten Änderungen der Genexpression bei. AU-reiche Elemente (AREs) 
sind Instabilitätsdeterminanten, deren Anwesenheit in den 3’ untranslatierten 
Regionen die schnelle Degradation der mRNAs verschiedener "early response" Gene 
induziert, darunter Cytokine, Wachstumsfaktoren und Protoonkogene. Die 
Aktivierung des p38 MAP Kinase/MAPKAP Kinase 2 (MK2) Signalwegs in HeLa 
Zellen induziert, wie von unserer Gruppe gezeigt, selektiv die Stabilisierung ARE-
enthaltender mRNAs. Dagegen führte die Einwirkung von UV-B Licht unabhängig 
von einem ARE und in p38/MK2 unabhängiger Weise zur Stabilisierung von 
mRNAs. Diese Beobachtungen warfen Fragen bezüglich der mRNA-Selektivität 
sowie der beteiligten Mechanismen beider Arten von mRNA-Stabilisierung auf. 
Zur Untersuchung der für die schnelle Degradation und die Stimulus-induzierte 
Stabilisierung von mRNAs erforderlichen Eigenschaften von AREs wurde in dieser 
Arbeit das ARE in der mRNA des chemotaktischen Cytokins IL-8 definiert. Durch 
Messung der Degradationskinetik von β-Globin mRNAs, die Fragmente der 3' 
untranslatierten Region von IL-8 enthalten, wurde das ARE in einem 60 Nukleotide 
langen Fragment mit strukturell und funktionell zweiteiligem Aufbau lokalisiert: einer 
AUUUA-Motive enthaltenden Kerndomäne mit begrenzter eigener 
Destabilisierungsfunktion und einer Hilfsdomäne, welche die von der Kerndomäne 
ausgeübte Destabilisierung verstärkt. Die Aktivierung von p38/MK2 stabilisierte 
mRNAs, die das komplette ARE oder lediglich die Kerndomäne enthielten. Die 
Stabilisierung durch ein bekanntes ARE-bindendes Protein- HuR- erforderte 
andersartige Sequenzen, die im IL-8 ARE fehlen, aber in anderen AREs wie dem von 
c fos und von GMCSF vorliegen. Das weist auf die Existenz von Untergruppen von 
AREs hin, die sich in ihrer Reaktionsfähigkeit gegenüber verschiedenen Arten der 
mRNA-Stabilisierung unterscheiden. Die Analyse der Länge von poly-(A) 
Schwänzen ARE-enthaltender mRNAs zeigte an, dass die Aktivierung des p38/MK2 
Signalwegs den Verlust des poly-(A) Schwanzes (Deadenylierung) hemmt, den 
initialen Schritt der mRNA-Degradation. Eine Rolle des poly-(A) Schwanzes und 
daran assoziierter Proteine bei der ARE-vermittelten mRNA-Degradation wurde 
durch Experimente mit mRNAs unterstützt, in denen der poly-(A) Schwanz durch 
eine Histon "stem loop" Sequenz ersetzt war. In Abwesenheit des poly-(A) 
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Schwanzes destabilisierte das ARE die mRNA nicht, und p38/MK2 Aktivierung hatte 
keinen Einfluss auf die mRNA-Stabilität, was auf einen Verlust der ARE-abhängigen 
Regulation hinwies. Die Deadenylierung von mRNAs wurde noch stärker in Zellen 
gehemmt, die UV-B Licht ausgesetzt wurden. Jedoch trat diese Hemmung 
unabhängig von einer p38/MK2 Aktivierung und auch in mRNAs ohne AREs auf. 
Eine Hemmung der mRNA-Degradation und Deadenylierung wurde bei weiteren 
zellulären Stressoren, Hitzeschock, osmotischen Schock und Einwirkung von H2O2, 
jedoch nicht bei γ-Strahlung beobachtet. Das spricht gegen die Beteiligung von DNA-
Schädigung als primärem Ereignis bei dieser Reaktion auf UV Licht. Eine Bedeutung 
der UV-vermittelten mRNA-Stabilisierung für die Entzündungsreaktion wird 
nahegelegt durch starke Hemmwirkungen auf die Degradation und Deadenylierung 
der endogenen IL-8 mRNA und durch Microarray Analysen, welche in HeLa Zellen 
sowie in der Keratinozyten-Linie HaCaT die Stabilisierung einer Gruppe an 
Entzündungen beteiligter Transkripte nachweisen. 
Diese Arbeit zeigt, dass mRNA-Stabilisierung durch verschiedene Auslöser in 
mechanistisch und bezüglich Transkriptselektivität unterschiedlicher Weise induziert 
wird. Weitere Experimente sind erforderlich, um die molekularen Prozesse und 



















Post-transcriptional mechanisms contribute to the rapid changes in gene expression 
induced by inflammatory/stress stimuli. AU-rich elements (AREs) are instability 
determinants whose presence in the 3’ untranslated regions induces rapid degradation 
of the mRNAs of several early response genes, including cytokines, growth factors 
and proto-oncogenes. Activation of the p38 MAP kinase/MAPKAP kinase 2 (MK2) 
pathway in HeLa cells was shown by our group to selectively induce the stabilization 
of ARE-containing mRNAs, whereas exposure to UV light led to stabilization of 
mRNAs independently of an ARE and in a p38/MK2 independent manner. These 
observations raised questions concerning the mRNA selectivity as well as the 
mechanisms involved in both modes of mRNA stabilization. To investigate the 
features of AREs required for rapid degradation and for stimuli-induced stabilization 
of mRNAs, the ARE in the mRNA of the chemotactic cytokine IL-8 was defined in 
this study. By measuring the degradation kinetics of β-globin mRNA containing 
fragments of the IL-8 3’untranslated regions, the ARE was localized to a 60 
nucleotide fragment with a structurally and functionally bipartite character: an 
AUUUA motif-containing core domain with limited destabilizing functions of its own 
and an auxiliary domain that enhances the destabilization exerted by the core domain. 
p38/MK2 activation stabilized mRNAs with the complete ARE or with the core 
domain alone. Stabilization by a well-known ARE-binding protein- HuR- required 
distinct sequences absent in the IL-8 ARE but present in other AREs like the c fos and 
GMCSF AREs. This suggests the existence of subsets of AREs differing in 
responsiveness to different modes of mRNA stabilization. Analyzing the poly-(A) tail 
lengths of ARE-containing mRNAs indicated that activation of the p38/MK2 pathway 
inhibits loss of the poly-(A) tail (deadenylation), the initial step in mRNA 
degradation. A role for the poly-(A) tail and its associated proteins in ARE-mediated 
mRNA degradation was supported by experiments with mRNAs in which the poly-
(A) tail was replaced by a histone stem loop sequence. In the absence of a poly-(A) 
tail the ARE did not destabilize the mRNA, and p38/MK2 activation had no effect on 
mRNA stability, indicating that ARE-dependant regulation was lost. Deadenylation of 
mRNAs was more strongly impaired in cells exposed to UV-B light. However, this 
inhibition occurred independently of p38/MK2 activation and also in mRNAs lacking 
AREs. Among other cellular stresses heat shock, osmotic shock and exposure to H2O2 
 4
but not γ-radiation were also observed to inhibit mRNA degradation and 
deadenylation, which argues against the involvement of DNA damage as the primary 
event in this response of UV light. A role for the UV-mediated mRNA stabilization in 
the inflammatory response is suggested by strong inhibitory effects on the degradation 
and deadenylation of the endogenous IL-8 mRNA and by microarray analysis which 
revealed the stabilization of a group of transcripts involved in inflammation in both 
HeLa cells and in the keratinocyte cell line, HaCaT. 
This study demonstrates that mRNA stabilization induced by different triggers differ 
mechanistically and with regard to transcript selectivity. More experiments are needed 























Keywords: AREs, mRNA, stability 
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2  INTRODUCTION: 
 
2.1 REGULATION OF GENE EXPRESSION: The transfer of genetic information from 
the level of the nucleotide sequence of a gene to the level of the amino acid sequence of a 
protein via the nucleotide sequence of RNA is termed gene expression. The entire process of 
gene expression in eukaryotes encompasses several steps including: 
• Transcription 
• Pre-mRNA processing 
• Translation 
 
Owing to the highly structured organization of eukaryotic systems, gene expression in 
eukaryotes needs to be tightly and precisely regulated in response to a variety of external 
cues. Due to the multitude of stages involved in gene expression, there are several potential 
regulatory sites including transcription, RNA processing, mRNA nuclear export and 
localization, mRNA decay, translation and posttranslational events. In addition to the long-
established transcriptional mechanisms regulating gene expression, the involvement of 
posttranscriptional gene regulation events, in particular alterations in mRNA stability is 
increasingly recognized. In mammalian cells, mRNA half-lives can range from less than 
20mins to 24hrs. These differences in mRNA decay rates have dramatic effects on the 
expression of specific genes, and allow the cell to effect rapid changes in transcript 
abundance. For example, the rate of mRNA turnover for individual mRNAs can vary in 
response to specific hormones  (Paek I 1987), viral infection  (Nishioka Y 1977),  (Rice AP 
1983), as a consequence of differentiation  (Jack HM 1988) or in response to inflammatory 
and stress stimuli  (Holtmann H 1999),  (Blattner C 2000),  (Bollig F 2002). These inducible 
effects on mRNA stability have the potential to change cytoplasmic mRNA concentrations 
rapidly without alteration in transcriptional activity and to augment the magnitude of mRNA 
induction by coordinating changes in transcription and mRNA stability. 
 
2.2 MECHANISM OF EUKARYOTIC mRNA DEGRADATION: All eukaryotic mRNAs 
bear terminal nuclear modifications at their 5’ and 3’ ends, in the form of the 7 methylated 
cap (7mGpppN) structure at the 5’ end and the poly (A) tail, which is a stretch of 100-250 
adenine residues, at the 3’end. In eukaryotes mRNA degradation can occur via one of four 
related, yet distinct pathways. In most cases the degradation of the transcripts begins with the 
shortening of the poly (A) tail at the 3’end of the mRNA, a process titled deadenylation  (Shyu 
AB 1991)  (Muhlrad D 1992). Three mRNA deadenylases have been identified. In yeast, the 
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predominant deadenylase complex contains two nucleases Ccr4p and Pop2p and several 
accessory proteins, Not1-Not5p, Caf4p, Caf16p, Caf40p and Caf130p  (Daugeron MC 2001),  
(Tucker M 2002),  (Tucker M 2001). Additional deadenylases include the Pan2p/Pan3p 
complex, first identified in yeast and proposed to be involved in cytoplasmic deadenylation in 
addition to its role in the trimming of the poly (A) tails of nascent transcripts in the nucleus  
(Boeck R 1996),  (Brown CE 1996),  (Tucker M 2001). Mammalian homologs of the yeast 
Pan2/Pan3 complex have also been recently identified and shown to have deadenylating 
activity in vitro  (Uchida N 2004). Another poly (A)-specific deadenylating nuclease- the 
RNase D homolog, PARN (poly (A) ribonuclease)- has been purified and biochemically 
characterized from both mammalian cells and Xenopus laevis oocytes  (Korner CG 1997),  
(Korner CG 1998). An as yet unresolved issue is the relative importance of these individual 
deadenylases in different organisms, for different mRNAs and in different physiological 
situations. 
 
In yeast, shortening of the poly (A) tail is followed by the removal of the 5’ cap structure 
(decapping) by the decapping enzymes, Dcp1p and Dcp2p  (Decker CJ 1993),  (Dunckley T 
1999),  (LaGrandeur TE 1998). This exposes the transcripts to digestion by the 5’ to 3’ 
exonuclease Xrn1p  (Muhlrad D 1994),  (Hsu CL 1993). Similar mechanisms exist in 
mammalian cells as well as are evident from the conservation of the decapping enzymes, 
Dcp1p and Dcp2p, among eukaryotes  (Lykke-Andersen 2002),  (van Dijk E 2002). Other 
observations also indicate that deadenylation precedes decapping in mammalian cells  





Figure 1:Deadenylation-dependent mRNA degradation pathways (Staton JM 2000) 
 
The proteins involved in mRNA decapping and 5’ to 3’ exonucleolytic decay have been found 
to localize to specific cytoplasmic foci, referred to as P bodies. In yeast, GFP-tagged Dcp1p, 
Dcp2p, and Xrn1p have been localized to P bodies  (Sheth U 2003). In mammalian cells 
analogous foci have been identified where the mammalian decapping factors co-localize,  
(van Dijk E 2002),  (Cougot N 2004), attesting to the conservation of decay mechanisms 
amongst eukaryotes. 
 
mRNAs can also be degraded in the 3’ to 5’ direction following deadenylation  (Muhlrad D 
1995). 3’ to 5’ degradation of mRNAs is catalyzed by the exosome, a multisubunit complex 
of 3’ to 5’ exonucleases functioning in several RNA degradative and processing events  
(Anderson AR 1998),  (Mukherjee D 2002),  (Rodgers ND 2002). 
 
Some eukaryotic mRNAs may also be degraded via endonucleolytic cleavage by a 
deadenylation independent process as has been shown for mammalian 9E3, transferrin 
receptor, c-myc, serum albumin, vitellogenin and Xenopus β-globin mRNAs  (Binder R 1994),  







Figure 2: Deadenylation independent mRNA degradation pathways (Staton JM 2000) 
 
Eukaryotic cells have also evolved quality control mechanisms, in the form of specialized 
pathways that degrade aberrant mRNAs containing either a premature translational stop codon 
(nonsense mediated decay) or those that do not contain a stop codon (non-stop decay). While 
the former involves decapping without prior removal of the poly (A) tail  (Muhlrad D 1994), 
the latter is effected via the cytoplasmic exosome and requires translation  (Frischmeyer PA 
2002). Therefore it appears that one major function of mRNA decay, apart from its role in the 
regulation of gene expression, is quality control, in order to ensure that only mRNA having an 
appropriate structure, i.e., cap, start codon, stop codon, and poly (A) tail survive. 
 
2.3 DETERMINANTS OF mRNA STABILITY: The cap and the poly (A) tail present at 
both ends of mRNAs play critical roles in mRNA translation and stability  (Gallie 1991),  
(Wickens M 1997). The role of the cap in mRNA stabilization has been demonstrated clearly 
first in Saccharomyces cerevisiae, and later in other eukaryotes, in which removal of the 5’-
terminus represents part of a common degradation pathway for stable and unstable RNAs  
(Tuite 1996),  (Muhlrad D 1994),  (Beelman CA 1996). 
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The poly (A) tail inhibits mRNA decay through its interaction with the poly (A)-binding 
protein (PABP1)  (Bernstein P 1989). As well as binding poly (A), PABP1 interacts with a 
specific region of the translation initiation factor eIF4G, which in turn forms a ternary 
complex with the cap-binding protein eIF4E  (Gingras AC 1999). This interaction circularises 
the mRNA in vitro,  (Wells SE 1998) and can simultaneously promote translation and stabilize 







Figure 3: The closed-loop model for translation and mRNA stability.  (R.Lewis 2003) 
 
Apart from the cap and the poly (A) tail that function as determinants of generalized mRNA 
stability, there are specific sequence elements which determine the difference in decay rates 
between stable and unstable mRNAs. There is little doubt that unstable mRNAs contain 
instability determinants, but it is as yet unclear whether stable mRNAs contain discrete 
stabilizing determinants or are stable by default. With the exception of a few stabilizer 
sequences, as for example the cytosine rich element in the 3’ UTR of the α globin gene  
(Weiss IM 1995), and similar elements in a few other genes  (Russel JE 1996),  (Holcik M 
1997), most identified elements promote mRNA destabilization. These sequences include the 
well-known adenosine (A) + uridine (U)-rich elements (AREs) located in the 3’UTR of many 
short lived mammalian mRNAs. 
 
2.3.1 AU-rich elements (AREs): The very short half-lives observed for transiently expressed 
genes, including early response genes such as lymphokines, cytokines and transcription 
factors is attributed to the presence of adenylate, uridylate-rich (AU-rich) instability elements 
(AREs) in their 3’ untranslated regions (UTRs). In 1986, Shaw and Kamen observed that an 
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ARE in the 3’UTR of granulocyte-macrophage colony stimulating factor (GMCSF) mRNA 
could stimulate the degradation of the normally stable β-globin mRNA  (Shaw G 1986). 
Similarly the 3’UTR of the c fos mRNA, which contains a 69nt ARE, was also observed to 
reduce the stability of the β-globin mRNA  (Chen C 1995),  (Chen CY 1995). Subsequently, 
AREs that function as RNA destabilizing elements were found in numerous mRNAs 
including that of certain hematopoietic cell growth factors, interleukins (eg. IL-6, IL-8, IL-3, 
IL-2)  (Winzen R 1999),  (Stoecklin G 2000),  (Lindstein T 1989), TNF α  (Lewis T 1998) and 
some proto-oncogenes. Recent computational analysis of the 3’UTRs revealed that as many as 
8% of human mRNAs contain AREs  (Bakheet T 2001). This finding suggests that AREs may 
account for the degradation of most unstable mRNAs.  
 
AREs were initially grouped into three classes according to their sequence features and decay 
characteristics  (Chen C 1995),  (Peng SS 1996). Class I AREs contain one to three scattered 
copies of the pentanucleotide AUUUA embedded within a U-rich region, found in c fos and c 
myc mRNAs. Class II AREs contain multiple overlapping copies of the AUUUA motif, only 
found in cytokine mRNAs. Class III AREs, such as the one in c-jun mRNA lack the hallmark 
AUUUA but contain a U-rich sequence. Bakheet and co-workers recently compiled a 
database of ARE containing mRNAs, and divided them into five groups  (Bakheet T 2001). In 
an attempt to reconcile both the experimental and computational classifications, Wilusz et al 






Table 1: Classification of AREs.  (Wilusz CJ 2001) 
 
Where W can be either A/U. It is now becoming increasingly clear that it is the combination 
of several functionally and structurally distinct sequence motifs, that determines the ultimate 
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destabilizing ability of each particular ARE  (Peng SS 1996),  (Chen CY 2002),  (Winzen R 
2004). 
 
The physiological importance of AREs in vivo has been evaluated for very few mRNAs. It 
was reported as early as in 1989 that removal of the ARE stretch correlates with increased 
oncogenicity of the proto-oncogene c fos  (Raymond V 1989). It was also shown that deleting 
the AU-rich region of the TNF gene in mice led to the development of chronic inflammatory 
arthritis and Crohn’s-like inflammatory bowel disease  (Keffer J 1991),  (Kontoyiannis D 
1999). Today it has been well established that several human cancer and inflammatory 
diseases, including certain B-cell lymphomas, neuroblastomas, and chronic inflammatory 
conditions are linked to ARE defects  (Conne B 2000). This is due to the fact that ARE-
mediated changes in mRNA stability are important in processes that require transient 
responses such as cellular growth, immune response, cardiovascular toning, apoptosis and 
external stress-mediated pathways. Hence a stabilization of ARE mRNAs can cause a 
prolonged response that may subsequently lead to a diseased state. 
 
Our understanding of the mechanism of ARE mediated mRNA turnover is far from complete. 
Some of the earliest observations from Chen and co-workers implied that AREs promote 
mRNA degradation by accelerating mRNA deadenylation  (Chen CY 1995). Recently it was 
shown that AREs could also act as potent stimulators of the decapping process  (Gao M 2001) 
and recruit the major component of the 3’ to 5’ degradation pathway-the mammalian 
exosome-either via direct binding or through their interaction with destabilizing ARE-binding 
proteins  (Mukherjee D 2002),  (Chen CY 2001),  (Gherzi R 2004). 
 
2.3.1.1 ARE-binding proteins: Numerous proteins have been described to bind AREs and 
designated as ARE binding proteins (ARE-BP) (review:  (Bevilacqua A 2003). Binding of 
these factors to transcripts bearing an ARE can have either a positive or negative effect on 
processes as diverse as stability, translation and sub-cellular localization of the mRNA.   
 
2.3.1.1.1 HuR: One of the best-characterized ARE-BPs is HuR, a 36 kDa ubiquitously 
expressed member of the ELAV (embryonic lethal vision) family of RNA binding proteins  
(Ma WJ 1996). There is evidence for the binding of HuR to ARE sequences in vitro  (Myer 
VE 1997),  (Fan XC 1997) and in vivo  (Atasoy U 2003),  (Lopez de Silanes I 2004). 
Overexpression studies demonstrated that HuR could stabilize messages containing class I 
and class II (and to a lesser extent class III) AREs by a mechanism that involves protection of 
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the RNA body rather than slowing the rate of deadenylation  (Fan XC 1998),  (Peng SS 1998),  
(Atasoy U 2003),  (Levy NS 1998),  (Rodriguez-Pascual F 2000). Other studies in which the 
HuR gene expression was downregulated by antisense RNA or siRNA approaches provided 
further evidence for the role of HuR in modulating mRNA turnover  (Wang W 2000),  (Wang 
W 2000). Like other Hu-family proteins, HuR contains three RNA recognition motifs (RRMs) 
and a novel shuttling sequence, HNS, located in the hinge region between its second and third 
RRM, which is crucial for the nuclear-cytoplasmic shuttling property of HuR  (Fan XC 1998). 
HuR’s ability to shuttle has led to the suggestion that HuR may initially become associated 
with target ARE-containing mRNAs in the nucleus and accompanies them into the cytoplasm 
where HuR is then able to exert its stabilizing actions (Brennan CM 2001). While this 
hypothesis remains to be proven, there is a growing body of evidence that links the 
cytoplasmic presence of HuR with its mRNA stabilizing functions  (Wang W 2002),  (Tran H 
2003). 
 
2.3.1.1.2 AUF1: Another well-characterized ARE-BP is AU binding factor 1(AUF1) or 
heterogenous nuclear ribonucleoprotein (hnRNP D), the first ARE-BP to be identified. It was 
first isolated on the basis of its ability to induce c myc mRNA decay in vitro  (Zhang W 1993). 
Subsequently AUF1 has been implicated in the regulation of many ARE containing mRNAs 
including GMCSF  (Buzby JS 1999), Bcl-2  (Lapucci A 2002) and IL-10  (Brewer G 2003) 
amongst others. AUF1 exists as a family of four protein isoforms with apparent molecular 
masses of 37, 40, 42 and 45kDa that are derived from an alternatively spliced pre-mRNA  
(Wagner BJ 1998) and that differ in their sequences at their N- and/or C-termini  (Wilson GM 
1999). All isoforms contain two N-terminal RRMs and a C-terminal domain containing Arg-
Gly-Gly (RGG) motifs  (Dempsey LA 1998). All isoforms are also primarily localized in the 
nucleus but the p37 and p45 isoforms exhibited shuttling properties as revealed by heterokaryon 
studies  (Arao Y 2000). This ability to shuttle appears to be essential for AUF1 to exert its 
effects on ARE containing mRNA  (Chen CY 2004). Transfection studies have shown that 
AUF1 can function as an mRNA destabilizing/stabilizing factor in a cell type specific manner  
(Loflin P 1999),  (Xu N 2001). Laroia et al on the other hand have proposed a model wherein 
targeted degradation of AUF1 by the ubiquitin-proteasome pathway is associated with the 
acclerated turnover of GMCSF ARE containing mRNA  (Laroia G 1999). Other studies have 
implicated AUF1 in the turnover of c fos mRNA directed by its major coding region 
determinant (m-CRD)  (Grosset C 2000) and in the accumulation of α-globin mRNA in 
erythrocytes  (Kiledjian M 1997). Recently Chen et al have demonstrated using cell-free 
decay systems that some ARE-BPs including AUF1 could recruit the mammalian exosome to 
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ARE containing RNA thereby mediating the degradation of ARE containing RNA  (Chen CY 
2001). These contradictory results raise the hypothesis that the function of ARE-BPs may be 
conditioned by the complexes in which they are integrated, and by the physiological 
conditions that shape the formation of these complexes. 
 
2.3.1.1.3 Tristetraprolin: Other ARE-BPs include Tristetraprolin (TTP), also known as 
Nup45, TIS11 or G0S24. TTP is the prototype of a group of CCCH tandem zinc finger (TZF) 
proteins, characterized by a CCCH zinc finger  (Thompson MJ 1996). Although TTP was 
originally thought to be a transcription factor, recent evidence indicates that TTP and its 
related proteins like Butyrate response factor 1 (BRF1) promote the turnover of ARE 
containing mRNA  (Carballo E 1998),  (Carballo E 2000),  (Stoecklin G 2002). Mice 
deficient in TTP develop a complex phenotype consisting of cachexia, dermatitis, 
conjunctivitis, destructive arthritis and autoimmunity  (Taylor GA 1996), all of which 
resembled earlier mouse models of TNF-α excess, thus implying a role for TTP in the 
regulation of TNF alpha synthesis, secretion, turnover, or action. Later it was demonstrated 
that TNF-α and GM-CSF mRNA are markedly stabilized in the cells from the TTP deficient 
animals  (Carballo E 1998; Carballo E 2000). The mechanism by which TTP destabilizes 
class II ARE containing mRNAs is not clearly understood but it was shown that the integrity 
of each of the two zinc finger motifs is required for binding and activity  (Lai WS 2002). It 
was also shown using cell-free systems that TTP and its related proteins could promote 
deadenylation and hence decay of ARE containing polyadenylated substrates by the 
mammalian deadenylase PARN  (Lai WS 2003). More recently it was shown that sequestering 
of TTP by 14-3-3 proteins in response to specific stimuli inhibited TTP dependent 
degradation of ARE containing transcripts  (Stoecklin G 2004). 
 
2.3.1.1.4 KSRP: Additional ARE-BPs like the KSRP (K homology Splicing Regulatory 
Protein) have been purified  (Chen CY 2001). KSRP was originally identified as a component 
of a protein complex that assembles on an intronic c-src neuronal –specific splicing enhancer  
(Min H 1997). It contains four RNA binding K homology (KH) motifs. KSRP was found by 
Chen et al to physically associate with the mammalian exosome  (Chen CY 2001), and that the 
isolated exosome then preferentially degrades ARE containing RNA. The group of Chen then 
went on to show that KSRP is required for rapid decay of ARE-containing mRNAs both in 
vitro and in vivo, and that the minimal active region is composed of the third and fourth KH 
motifs, which together mediate high-affinity binding to the ARE, whereas the third KH motif 
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alone is responsible for interaction with poly (A) ribonuclease, PARN and the exosome  
(Gherzi R 2004). 
 
Inspite of intensive study, the question as to how these proteins alter mRNA stability remains 
to a large extent unanswered. One possibility is that ARE-protein complexes alter interactions 
between PABP and poly (A), or between eIF4E and the 5’ cap, thereby providing access to 
exonucleases or deadenylases. 
 
 
igure 4: Model to show how the AREs mediate mRNA destabilization and stabilization. (Wilusz CJ 











transcriptional control of gene expression is that trans-acting factors like the ARE-
play a critical role in modulating the rate of degradation of distinct mRNAs involved in 
cellular responses to environmental and/or metabolic changes. Consistent with this possi
are previous observations that some AREs are inactive in selected cell lines and that AREs 
can be differentially regulated in response to particular extracellular stimuli  (Nair AP 1999)
(Schiavone N 2000). Since small differences in half-lives can alter the abundance of a given 
mRNA, stabilization of otherwise labile ARE-containing mRNA contributes to their strong 
and rapid induction. This level of post-transcriptional control affords an additional degree of
flexibility in the expression of a large number of transcripts that play essential roles in growth
 15
control, differentiation, immune activation, and in rapid response to extracellular stimuli  
(Koeffler HP 1988),  (Ernst TJ 1989). Early reports described the altered turnover of ARE
containing mRNAs in response to extracellular as well as internally generated signals, such
phorbol esters, antibodies recognising CD3/CD28 surface receptors and TNF α  (Bickel M 
1990),  (Gorospe M 1993),  (Lindstein T 1989). Protein kinase C (PKC) was specifically 
implicated in the enhanced stability of many labile mRNAs, such as those encoding p21 a
IL-1  (Gorospe M 1993),  (Park JW 2001). The mitogen-activated protein kinases (MAPK) 
have also been implicated in regulating mRNA turnover. These include the Jun-N-terminal 
kinase (JNK) signalling pathway, which was found to participate in the stabilization of ARE
containing IL-3 and IL-2 mRNAs  (Chen CY 1998),  (Ming XF 1998), phosphatidylinositol-3-
kinase  (Ming XF 2001), and p38 mitogen-activated protein kinase pathways  (Dean JL 1999),
















activated protein kinases. Stress signals, such as lipopolysaccharides (LPS) in lymphoid c
heat shock and ultraviolet light or pro-inflammatory cytokines like IL-1 or TNF α can initiate 
signalling cascades resulting in the activation by dual tyrosine/threonine phosphorylation, of 
p38  (Rouse J 1994)  (Freshney NW 1994),  (Han J 1994). Activation of this pathway affects a
variety of cellular processes including cell division, apoptosis, invasiveness of cultured cells 
and the inflammatory response  (Xia Z 1995),  (Takenaka K 1998),  (Lee JC 1994). p38 MAP
kinase activates many protein kinases including the MAP-kinase activated protein kinases 2, 
MK2  (Stokoe D 1992). 
 
O
activation of the p38 MAPK induces the stabilization of several ARE-containing endogenous
mRNAs and reporter mRNAs containing different AREs including those of IL-3, IL-6, IL-8, 
TNF α, cyclooxygenase 2, and c fos, via the activation of its substrate MK2  (Kotlyarov A 
1999),  (Lasa M 2000),  (Neininger A 2002),  (Winzen R 1999). In the case of TNF α alone,
the ARE-mediated regulation via the p38 MAP kinase pathway appears to be at the level of 
translation  (Willeaume V 1995)  (Kotlyarov A 1999),  (Neininger A 2002). The mechanism b
which the p38 MAPK/MK2 pathway controls the translation and stability of ARE-containing 
mRNA is as yet unknown but a working hypothesis is that this involves the phosphorylation 








igure 5: Scheme showing the role of the p38 MAPK/MK2 pathway in the stabilization of ARE-

























ARE-BP tristetraprolin (TTP), yet the effect of this kinases on TTP activity is controversi
(Carballo E 2001),  (Mahtani KR 2001),  (Zhu W 2001). It was observed that phosphorylation
promotes the nuclear export of TTP, an effect that is partly dependant on 14-3-3 proteins  
(Johnson BA 2002). 14-3-3 proteins, by interacting with phospho-serine residues, are 
associated with a large number of partner proteins and thus influence a wide range of c
processes  (Tzivion G 2001). Recently it was reported by Stoecklin et al that MK-2 induced 
phosphorylation of TTP at serines 52 and 178 promoted the assembly of TTP: 14-3-3 
complexes and that this binding inhibits the degradation of ARE-containing transcripts
(Stoecklin G 2004).  
 
O
containing mRNA (in this case IL-3 mRNA) under resting conditions, and that HuR and other
yet-to-be-identified ARE-BPs under the influence of specific signalling pathways (in this case 
PI3-K and p38 MAPK) overcome the TTP-mediated decay  (Ming XF 2001). While HuR 
itself is not a phosphoprotein, a critical remaining question is the mechanism by which Hu
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exerts its stabilizing influence on labile mRNAs. Since HuR is predominantly localized in the
nucleus, it has been proposed that the mRNA-stabilizing influence of HuR requires its 
translocation to the cytoplasm  (Atasoy U 1998),  (Fan XC 1998),  (Wang W 2000). An 
examination of signalling events that control HuR subcellular localization have uncover
critical participation of the AMP-activated kinase (AMPK), also known as cellular sensor of 
metabolic stress  (Wang W 2002), the ERK pathway  (Yang X 2004) and the p38 pathway 




ther proteins that have shown to be phosphorylated by MK2 and selectively interact with 
the 











AREs include hnRNP A0  (Rousseau S 2002) and PABP1  (Bollig F 2003). Inspite of the 
expanding list of ARE-BPs that are being characterised, it remains to be seen how exactly 
p38 MAPK/MK2 pathway regulates the stability of ARE-containing mRNAs. 
 
2
adverse agents such as carcinogens, metal toxins, oxidants and radiation can induce signa
transduction cascades and changes in gene expression. Ultraviolet (UV) radiation of variou
wavelengths has received much attention. The human population is intermittently yet 
chronically exposed to ultraviolet radiation (UVR) from the sun. UVR is primarily 
responsible for more than 1,000,000 cutaneous malignancies each year in the USA a
(Miller DL 1994), making it the most efficient environmental carcinogen known. Acute an
chronic effects of UVR on skin include inflammation, hyperpigmentation, hyperplasia and 
skin cancer  (Norris PG 1993),  (Young AR 1993),  (Gilchrest BA 1999),  (Gilchrest BA 199
The biological effects of UVR have been mainly attributed to the UVB (280-320nm) fraction, 
while the potentially dangerous UVC (100-290nm) radiations are absorbed by the ozone layer  
(Madronich S 1998). UV-A (320-400nm) effects are primarily oxidative in nature. 
 
S
activation of immediate early genes such as c fos and c jun  (Devary Y 1991),  (Buscher M 
1988). This UV response is triggered through signal transduction, which originates from on
of several primary UV target molecules: DNA lesions in the form of pyrimidine dimers and 6-
4 photoproducts introduced through irradiation  (Blattner C 1998),  (Schorpp M 1984),  
(Patrick 1977), through damaged ribosomal RNA  (Iordanov MS 1998), through the rele
reactive oxygen species (ROS)  (Peus D 1999),  (Peus D 2001),  (Peus D 1999),  (Klotz LO 
2001), or through the inactivation of oxidation-sensitive protein tyrosine phosphotases  
(Herrlich P 2000),  (Knebel A 1996). UV irradiation activates several signal transduction
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pathways including ERK, JNK and the p38 MAPK pathways  (Tyrrell 1996),  (Bender K 
1997).  
 





ot much has been reported about the direct effects of UV light on mRNA stability. Blattner 
 
expression have, as yet, received less attention. Stabilization of protein is responsible for th
UV-DNA lesion-induced increases in p53 and E2F-1 levels  (Blattner C 1999),  (Blattner C 
1999),  (Maltzman W 1984). Other results indicate an increase in p53 translation following 
UV-C irradiation via binding of HuR  (Mazan-Mamczarz K 2003). In addition it was shown
that UV irradiation induces phosphorylation of eukaryotic translation initiation factor 2 on th
alpha-subunit (eIF2α) and inhibits protein synthesis in a dosage- and time-dependent manner  
(Wu S 2002). Recently it has also been demonstrated that as a consequence of the abortive 
translation initiation that accompanies exposure to environmental stresses including UV 
irradiation, those mRNAs whose translation is aborted are routed to specific cytoplasmic 
referred to as Stress Granules (SGs)  (Kedersha N 2002),  (Kedersha N 2000),  (Kedersha N 
1999). It has been proposed that these SGs could be sites of mRNA triage, where the fates of 
specific mRNA transcripts are determined by the activity of different RNA-binding proteins 
like HuR and TTP  (Stoecklin G 2004). 
 
N
et al showed UV-C induced stabilization of c fos and other short-lived mRNA like c jun, c 
myc, IκBα and Kin17  (Blattner C 2000). Similarly Wang et al reported the UV-C mediated
stabilization of p21 mRNA by HuR  (Wang W 2000). Our group showed that UV-B could 
induce stabilization of several short-lived reporter mRNAs-both ARE and non-ARE 


















Figure 6: Scheme showing differences between UV mediated mRNA stabilization and the p38 
MAPK/MK2 pathway mediated stabilization of ARE-containing RNAs 
 
 
UV light is a potent inducer of inflammation like LPS and IL-1 and induces the expression of 
numerous cytokines and oncogenes  (Tyrrell 1996),  (Herrlich P 1997). We believe that a part 
of this induction could be a result of mRNA stabilization. This idea has been reinforced by a 
recent report that reveals that mRNA stabilization and destabilization significantly influenced 
the expression of approximately 53% of stress-regulated genes out of a total of 1,152 genes 
examined using a cDNA array  (Fan J 2002).  
 
2. 5 AIMS OF THE STUDY: The aim of this study was to obtain a deeper understanding of 
different modes of regulated mRNA turnover and their relationship to each other. Although 
much work has been done defining and characterizing the AU-rich elements, their mechanism 
of action is still unclear. The aim of the first part of the study was to identify sequence 
features of AREs that determine their destabilizing activity and their responsiveness to p38 
MAPK/MK2 pathway induced stabilization using the IL-8 AU-rich element as the 
experimental model. The stabilization of ARE-containing RNA by the p38 MAPK/MK2 
pathway could be effected via an inhibition of any one/more of the processes involved in 
mRNA degradation including deadenylation, decapping or exonucleolytic decay of the 
mRNA body. The aim of the second part of the study was to examine the effects of p38 
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MAPK activation on deadenylation, the first stage in the mRNA degradation process, and to 
thereby improve our understanding of the mechanism of action of the p38 MAPK/MK2 
dependant stabilization of ARE-containing RNA. UV light stabilizes short-lived ARE- and 
non-ARE containing reporter transcripts in a p38 MAPK/MK2 pathway independent manner. 
The aim of the last part of the study was to similarly characterize the mechanism behind this 
stabilization by examining effects of UV light on deadenylation and to identify the signalling 
pathway/s that are involved in this effect of UV light. 
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Plasticware, disposable material- including 2ml, 5ml and 10ml pipettes, tips and eppendorfs, 
and petri dishes for cell culture, cell culture flasks etc., were bought from the firms- 
Eppendorf, Sarstedt, Greiner and Nunc. 
 
3.1.2 Equipment: 
• Electrophoresis-, Western blot- and Photographic systems: 
Biometra -BioDoc Analyze UV transilluminator 
Biorad-Gel Doc 1000 System 
AGFA- Duoscan (scanner) 
Amersham Pharmacia Biotech- Electrophoresis Power supply- EPS301 
Amersham Pharmacia Biotech- Electrophoresis Power supply- EPS300 
GIBCO BRL Life technologies- Electrophoresis Power supply- ST305 
Hoefer Scientific Instruments- Mighty Small II SE250- chamber for PAGE  
SIGMA- Model Z37, 507-1-electophoresis chamber for big SDS PAGE gels. 
Peqlab biotechnologie- Semi-dry electroblotter 
• Microscope and Spectrophotometer: 
Zeiss- Axiovert 40 CFL (fluoroscent microscope) 
Leica- DMIL (light microscope) 
Dynatech- MR6500 ELISA reader 
Shimadzu- Spectrophotometer UV-160A 
Pharmacia- Pharmacia LKB Ultrospec III-spectrophotometer 
• Assorted equipement: 
Eppendorf- thermomixer 5436 
Roth- test tube thermostat TCR 100 
GFL- (-80ºC) 
Liebherr- Glassline (4ºC and -20ºC) 
LTF labortechnik-Stratolinker 
Omnilab- Heidolph MR 2002, MR 3001K-magnetic stirrers 
Omnilab- REAX 2000-vortex 
Bender and Hobein- Genie 2-vortex 
Samsung- M187DN-microwave 
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Lauda- E100-water bath with shaking 
B.Braun Biotech international- horizontal shaker 
Landgraf- thermocycler 
Perkin Elmer- ABI PRISM 310 Genetic Analyzer (DNA sequencer) 
Protec Optimax- Film Developer 
Ziegra- Icemachine 
Schott- CG840B- pH meter 
• Hybridization ovens: 
MWG- Hybaid 
G.Kisker- Hybridization oven, Model 6/12 
• Weighing scales: 
Omnilab- OL110-A 
• Bacterial culture: 
New Brunswick scientific- Innova 4230 (Refrigerated incubator shaker) 
Shel lab- Incubator shaker 
• Cell culture: 
Forma Scientific-CO2 water-jacketed incubator 
Grant OLS 200- water bath in cell culture 
Heraeus instrumnts- 222 Hera safe (laminar hood) 
• Centrifuges: 
Heraeus instruments- Labofuge 400R (centrifuge) 
Sigma- laboratory centrifuge 3K30 
Sigma- tabletop centrifuge 1-15 
Eppendorf- tabletop centrifuge 5415C 
Sorvall- RC5C 
 
3.1.3 Chemicals and Solutions: All chemicals-powdered and solutions-, analytical grade or 
cell culture tested, were obtained from Fluka, Merck, Serva, SIGMA-Aldrich, BIOMOL, 
ROTH and J.T.Baker. 
 
3.1.4 Enzymes and Enzyme Buffers: All the enzymes used in the course of the study were 






3.1.5 Buffers and Solutions: 
 
Loading Buffer (DNA-, RNA- Gel electrophoresis) 
50 % (v/v) Glycerol  
0.4 % (w/v) Bromphenolblue   
1 mM EDTA pH 8,0 
 
10X Detection solution (Northerns) 
0.1 M Tris-HCl 
0.1 M Sodium Chloride (NaCl)   
pH set to 9.5 
 
2X HEBS 
16.4 g/l NaCl  
11.9 g/l  HEPES 
0.21 g/l Disodium hydrogen phosphate (Na2HPO4) 
pH set to 7.12 
 
Hybridization solution (for DIG based Northerns) 
10.0 ml Formaldehyde 
 5 ml 20 x SSPE 
 4  ml 10 x Blocking solution 
0.2 ml 10% (w/v) N-Laurylsarcosine 
0.02 ml 20% (w/v) SDS  
 .760  ml H2O 
 
2X Maleic acid solution 
0.1 M Maleic acid 
200 mM NaCl                                                                                                                






10X MOPS  
200 mM  3-(N-Morpholino)propanesulphonic acid 
50  mM Sodium acetate 
10 mM EDTA 
pH set to 7.0 
 
20X SSC 
3 M NaCl 
300 mM Tri-sodium citrate 
pH set to 7.0 
 
20X SSPE 
3 M NaCl 
200 mM Sodium dihydrogen phosphate (NaH2PO4) 
20 mM EDTA    
pH set to 7.4 
 
50X TAE  
2 M Tris 
0,1 M EDTA  
pH set to 8.0 using acetic acid  
 
TSS solution (bacterial transformation) 
10 % (w/v) Polyethylenglykol 6000 
5 % (v/v) dimethylsulfoxide (DMSO) 
50 mM Magnesium sulphate (MgSO4) 
in LB-Medium  
 
Extraction Buffer (for mammalian genomic DNA preparation) 
10 mM Tris-HCl (pH 8.0)                                                                               
0.1 mM EDTA (pH 8.0)                                                                               




3.1.6 Ready-to-use buffers and solutions: 
Dulbecco’s modified eagle medium (DMEM)- PAA 






1M Tris-HCl (pH from 7.2 to 8.0)- Sigma 
3M Sodium acetate (pH 5.2)- Sigma 
30% Acrylamide-bis acrylamide solution-ROTH 
 
3.1.7 Inhibitors :  





3.1.8 Other materials and substances: 
Hybond N Membrane- Amersham 
Immobilon PVDF membrane- Millipore 
Neubauer cytometer- Superior Marienfeld 
X ray film cassettes- Applied Gene Technology Systems 
X ray films- Kodak 
CSPD- Roche diagnostics 
DIG-11-UTP- Roche diagnostics 
Filter paper 3MM- Whatmann 
 
3.1.9 Primers: 
All primers were ordered from the company MWG Biotech. 

















3.1.10 Bacterial strains: 
• E.coli K12 LK111λ 
• E.coli JM109  
• E.coli XL1 blue  
 
3.1.11 Cell lines: 
• HeLa   ATCC CCL2 epithelial cervical carcinoma 
• HeLa- tTa   HeLa cells stably transfected with the tetracycline sensitive     
                              Transactivator  (Gossen M 1992) 
• HaCaT  A spontaneously transformed human epithelial cell line from  
adult skin  (Boukamp P 1988). An aliquot of frozen cells were obtained 
from Dr. Detlef Neumann, Institute of Molecular Pharmacology, 
Medical School, Hannover. 
 
3.1.12 Plasmids: 
• ptetBBB   (Xu N 1998)  
• ptetBBB GMCSF  (Xu N 1998) 
• ptetBBB c fos   (Winzen R 1999) 
• ptetBBB IL8 (972-1310) (Winzen R 1999) 
• ptet myc-HuR   a kind gift of Dr. A. B. Shyu, Houston, USA 
• pCDNA3 MKK62E  (Winzen R 1999) 
• pCDNA3 MK2K76R  a kind gift of Dr. M. Gaestel, Hannover, Germany 
• pCDNA3 hcatalase  a kind gift of Dr. S. Lortz, Hannover, Germany 
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• pUHD10 CAT-TIMP1 (Bollig F 2002) 
• pEGFP-C1   Clontech 
 
3.1.13 Kits: 
• QuickChangeTM kit for site directed mutagenesis from Stratagene. 
• Nucleospin RNA II (250 preps) for RNA isolation from Macherey Nagel 
• Nucleospin Ax for plasmid maxi-preps from Macherey Nagel 




3.2.1 Cell culture: 
 
3.2.1.1 Passaging and Handling: All cell culture techniques were performed under sterile 
conditions in the hood. Only disposable plastic ware-pipettes, 50ml falcon tubes, petri dishes, 
and culture flasks were used. The medium that was predominantly used for the culturing was 
Dulbecco’s modified eagle medium (DMEM).  Fetal calf serum (FCS), to a final 
concentration of 5% or 10%, L-Glutamine, penicillin and streptomycin were added to usually 
500ml of the ready-to-use DMEM medium just before use. This medium was then stored at 
4°C for some weeks. The medium was always prewarmed to 37°C before use. Similarly the 
1XPBS prepared from the 10X stock, and the 1X trypsin-EDTA solution were also stored at 
4°C, and prewarmed to 37°C before use. The cells were normally cultured in medium 
supplemented with 5% FCS. For passaging, the cells were allowed to reach confluence, and 
then the medium was discarded. The cells were washed carefully with warm PBS twice. Then 
an appropriate amount of trypsin-EDTA (according to the size of the culture flask or petri 
dish) was added to the cells. The cells were then incubated at 37°C for 2-3mins until they 
detached from the surface of the culture vessel. Fresh medium was immediately added to the 
cells, and the cells were split into an appropriate number of culture flasks according to the 
need and the period before the next passage. 
 
3.2.1.2 Counting the cells: The cell count was determined using the Hemocytometer  
(Neubauer Chamber). An aliquot of the cell suspension obtained after trypsinizing the cells 
was diluted 1:1 with Trypan Blue (0.8% v/v in PBS). Trypan Blue is a cell permeable dye; 
while living cells are able to extrude the dye, dead cells are unable to do so and hence stain 
blue. To obtain an accurate count, the cells have to be uniformly distributed over the entire 
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chamber. The chamber is divided into 9 squares. Each square has a surface area of 1sq.mm 
and the depth of the chamber is 0.1mm. To get the final count in cells/ml, first divide the total 
count by 0.1mm (chamber depth) then divide the result by the total surface area counted.  
 
3.2.1.3 Freezing and thawing cells: Cells that are to be frozen are cultured until they reach 
confluence. One 75cm2 flask of cells was prepared for one freezing ampoule. Each freezing 
ampoule was labeled with the name of the cell line and the date of freezing. The freezing 
medium contains: 
    70% growth medium 
   10% DMSO 
   20% FCS 
The cells were trypsinized, and spun down by centrifugation. They were then resupended in 
the appropriate amount of ice cold freezing medium (1ml per ampoule) and transferred to the 
ampoule, which was then placed in a freezing box. The box was left at -80ºC for at least 
24hrs. Thereafter the ampoules can be transferred to storage in liquid nitrogen. 
 
For thawing cells, an ampoule was taken from the liquid nitrogen and allowed to thaw in 
warm water until only a small piece of ice is left. The cell suspension was transferred to a 
15ml centrifuge tube. 1ml of cold FCS was added drop-wise to the cells, with gentle mixing. 
10ml of growth medium containing 15% FCS was then added to the cells in portions with 
gentle mixing. The cells were spun down, and the cell pellet was resuspended in 1ml of the 
growth medium containing 15% FCS, after which the cell suspension was transferred to 
75cm2 flask containing 25ml of the same growth medium and allowed to grow at the 
appropriate growth temperature until they reach confluence. 
 
3.2.1.4 Transient transfections: Transient transfections of the HeLa tTA cells were done 
using the Calcium chloride-HEBS method. In brief, appropriate numbers of cells were seeded 
in petri dishes (4 x 106 for a dish 9cm in diameter) the day before the transfection was to be 
done, such that the cells reach a state of sub-confluence on the day of the transfection. The 
next day the medium in the dishes was replaced with fresh medium containing 10%FCS 
atleast an hour before the actual transfection was to be done. 250mM calcium chloride 
solution was prepared fresh from the 2.5M stock solutions. Then equal volumes of the 
250mM calcium chloride solution and 2X HEBS solution (pH 7.12, set at RT) were tested 
against each other in a small glass tube for the formation of a thin white precipitate at the 
interface of the two solutions, taking care to add the prewarmed HEBS drop by drop along the 
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sides of the tube. Now the required amounts of the plasmids (30µg for a 9cm dish) to be 
transfected were added to the appropriate amounts of the calcium chloride solutions aliquoted 
in the glass tubes. Then equal volumes of the 2X HEBS solution were added individually to 
each tube, making sure a precipitate was formed in each case. Each mixture was allowed to 
stand at RT for 2mins, mixed well and then added to the cells to be transfected in the petri 
dishes. 4hrs after the transfection, a glycerol shock was given to the cells using a 10% 
glycerol solution prepared in warm DMEM. An appropriate amount of the 10% glycerol 
solution (2ml for a 9cm dish) was added to the cells, after removing the medium that was 
previously covering the cells. The glycerol-medium mixture was allowed to stand on the cells 
for 2mins. Then the glycerol was removed and the cells were washed twice with warm PBS 
and fresh medium added. 2hrs after the glycerol shock the cells were trypsinized and reseeded 
in parallel cultures as per the requirements for the assay to be carried out. Any assay that was 
to be done with the transfected cells was always done on the third day. 
3.2.1.5 Preparation of lysates for RNA extraction: For the preparation of lysates, the 
transfected cells (about 24hrs after the transfection) were washed with cold PBS, and the 
appropriate amount of the RNA lysis buffer (from Macherey Nagel) was added to the cells, 
the lysates frozen in liquid nitrogen and stored at -80°C. 
 
3.2.2 Bacterial transformations and cloning: 
 
3.2.2.1 Preparation of competent cells: 3ml cultures of E.coli (LK111λ/JM109/XL1blue) 
were grown in LB overnight at 37ºC. The next day the 3ml cultures were inoculated into 
100ml of LB each and allowed to grow at 37ºC in a shaker. In the meantime the 
transformation stop solution (TSS) was prepared fresh (ref section 3.1.5 for composition). 
When the OD600nm reached 0.3-0.4, the cultures were spun down at 2000 RCF(g), 4ºC for 
10mins. To each pellet 1/10 the volume of 1XTSS (10ml for a 100ml culture) was added, the 
pellets resuspended in the same and incubated on ice for 2mins. Then 200µl aliquots were 
made and stored at -80ºC. 
 
3.2.2.2 Bacterial transformation: The competent cells were first thawed on ice. The 200µl 
of competent cells were taken in special blue-capped tubes. 5ngs of the plasmid DNA (in the 
case of a control plasmid like bluescript or 5µl of the ligation mix) was mixed with the 
competent cells. The mixture was left on ice for 30mins. Then the mixture was heat shocked 
at 42ºC for exactly 45secs. Then the samples were placed for 2mins on ice. Now 800µl of LB 
without ampicillin was added to each sample and the cells were allowed to recover for 1hr at 
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37ºC in a shaker. Then the cells were spun down in an eppendorf, 800µl of the supernatant 
was discarded and the pellets were resuspended in the remaining 200µl of LB. The 200µl 
suspensions were spread plated on LB plates containing the appropriate antibiotic (100µg/ml 
of ampicillin for   LK111λ). The next day the plates were checked for the presence of 
transformed colonies. The transformation efficiency is calculated as the number of colonies 
per µg of plasmid DNA transformed. 
 
3.2.2.3 Preparation of glycerol stocks: 3ml liquid cultures of the bacterial clones that were 
to be stored were grown O/N at 37ºC. The next day, 200µl of 100% glycerol stock solution 
was pipetted out into the cryovials, which had already been labeled. 800µl of the O/N cultures 
were added to the glycerol and mixed well using a vortex. They were then immediately frozen 
in liquid nitrogen and stored thereafter at -80ºC. 
 
3.2.2.4 Plasmid preparations: Mini plasmid preparations were done using the GFX (ref 
section 3.1.13) kit according to the manufacturer’s instructions. Maxi-preparations were also 
done using the Nucleobond kit from Macherey Nagel, according to the manufacturer’s 
instructions. 
 
3.2.2.5 Quick check of clones: This is a simple and easy procedure to test the size of 
plasmids for the presence or absence of an insertion or deletion. 50µl of phenol-chloroform 
mix and 10µl of the DNA loading dye were aliquoted into microfuge tubes. 100µl of 
overnight E.Coli liquid cultures grown in LB with or without Ampicillin for selection were 
added to the tubes. The mixtures were vortexed well and spun for 3mins in a microcentrifuge 
at RT. 20-30µl of the supernatant were loaded into a conventional 0.6-0.8% agarose gel. 
 
3.2.3 MOLECULAR BIOLOGY 
 
3.2.3.1 Isolation of RNA from mammalian cells: RNAs were isolated from mammalian 
cells in culture using the Nucleospin kit from Macherey Nagel (ref section 3.1.13). The 
principle behind the isolation was very simple. Cells were lysed using the lysis buffer 
provided with the kit. The appropriate amount of the lysate was added to Shredder columns to 
homogenize the lysate. Freshly prepared 70% ethanol was then added to the homogenized 
lysates to bind the nucleic acids. This mixture was then added to Columns, which had silica 
gel matrices that bound the RNA from the lysates. After suitable washes to remove 
contaminating DNA and proteins, pure RNA was eluted in 30-50µl of RNase free water. 
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3.2.3.2 Mammalian Genomic DNA extraction: HeLa tTA cells were grown in a flask until 
they were confluent. The cells were washed twice with ice cold PBS. Then using a policeman, 
the cells were scraped into 500µl of PBS. The collected cells were transferred into a 50ml 
centrifuge tube. The flask was washed again with 1ml of PBS and the remnant cells added to 
the collected cells. The cells were pelleted down by centrifuging at 1000 RCF(g) for 10mins 
at 4ºC. The cell pellet was resuspended in 5ml of cold PBS and the centrifugation repeated. 
Now the cells were resuspended in 2ml of TE (pH 8.0), and aliquoted into two-50ml 
Erlenmeyer’s flasks. Now 10ml of extraction buffer was added to each flask. Proteinase K 
was added to a final concentration of 0.1mg/ml to each flask and mixed well using a pipette 
tip. The flasks were now incubated at 50ºC for 3hrs. The lysed cell suspensions were now 
transferred into two-50ml centrifuge tubes. 12ml of phenol-chloroform mixture was added to 
the suspensions and centrifuged at 5000 RCF(g) for 15mins at RT. The organic phase was 
discarded and 11ml of chloroform was added and the centrifugation repeated. The organic 
phase was again discarded and the chloroform extraction repeated. The aqueous phase was 
transferred to a fresh tube. 5ml of 7.5M ammonium acetate and 20ml of absolute alcohol was 
added to each tube, the tubes swirled gently until a clear stringy precipitate forms in the tubes. 
Now using a 1ml pipette the precipitates were collected and transferred to a fresh tube, the 
remnant alcohol removed, and the DNA allowed to dry for about 1/2hr. The dried DNA 
pellets were resuspended in about 500µl of DNase free water and incubated O/N in a shaker at 
37ºC. to allow the DNA to dissolve. The concentration of the DNA was measured 
spectrophotometrically and the quality of the DNA checked on an agarose gel. 
 
3.2.3.3 Spectrophotometric estimation of the concentration of nucleic acids: The 
concentration of nucleic acids was measured spectrophotometrically by measuring their 
absorption at 260nm. The concentrations were calculated using the following standard values: 
 1 OD260nm = 40µg RNA/ml 
 1 OD260nm = 50µg DNA/ml 
 
3.2.3.4 Agarose gel electrophoresis for the separation of nucleic acids: For analysis of 
DNA samples, usually 1% agarose gels were made. 1g of agarose was dissolved by heating in 
a microwave in 100ml of 1XTAE. After allowing the melted agarose solution to cool to about 
65ºC, about 2µl of a concentrated stock solution of ethidium bromide was added, mixed 
gently and poured immediately into the previously set up gel platform. The gel was allowed to 
solidify at RT. The DNA samples were mixed with the DNA loading buffer and loaded onto 
the wells. Then the gel was run in the electrophoresis chamber using 1X TAE as the running 
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buffer at the required current conditions (50-100V for 45-90mins). Usually a standard DNA 
marker was also loaded to control for the quality of the gels as well as to help estimate the 
size of the DNA fragments being examined. The gel was then photographed in a Gel Doc. 
 
3.2.3.5 RNA gels: The required amount of agarose, depending on the % required, was 
dissolved in deionized water by boiling. Then the required amounts of 10X MOPS solution 
and formaldehyde solution were added and the gel poured immediately into the gel platform. 
   
  Total gel volume   300ml 
  Deionized water  214.8ml 
  Agarose    3g (1%) 
  37% formaldehyde  55.2ml 
  10X MOPS   30ml 
 
Prepare 5-20µg of total RNA in deionized water. A master mix of the loading buffer was 
prepared 
 
   
10X MOPS   1.5µl*X 
  37% Formaldehyde  3.75µl*X 
  1mg/ml Ethidium bromide 1µl*X 
  RNA loading dye  8.75µl*X 
 
Where X is the no. of samples. Equal amounts of the RNA sample and the loading buffer 
were mixed with each other. The mixtures were vortexed briefly, then heated to 65ºC for 
15mins, spun down, mixed well once again and loaded onto the gel/s. The gels were run at 
120V until the dye front migrated halfway down the gel. 
 
3.2.3.6 Northern transfer: The RNA gels were visualized under a transilluminator and 
photographed, so that a record of the quality of the RNA and the quantity (equal loading) can 
be made. Then the gels were rinsed in distilled water two times, 30 mins each time to wash 
off the excess formaldehyde fumes. The gels were then rinsed in 10X SSC for about 20 mins 
and in the meantime the transfer apparatus set up, using a glass dish, 10X SSC and a 
whatmann wick. The gels were blotted onto 0.45µm nylon membranes. The membranes were 
cut to the sizes of the gels to be transferred, and soaked briefly in 10X SSC. The membranes 
were then placed over the gels that had previously been placed on the transfer apparatus, 
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taking care to roll out air pockets if any. This was covered by two pieces of 3MM whatmann 
paper once again cut to the size of the gels which had also been briefly soaked first in distilled 
water and then in 10X SSC, followed by a stack of paper towels/diapers, and a weight was 
placed over the whole set-up. The transfer was allowed to take place for about 20hrs. Then the 
membranes were baked for about 10mins at 80ºC, and crosslinked using either a UV 
transilluminator (1min 15secs) or simply using a crosslinker. 
 
3.2.3.7 Hybridization of Northern blots: The blots were presoaked in 2X SSC. The blots 
were now incubated with the pre-hybridization solution at 68ºC for atleast 2hrs the volume 
used depending on the size of the blots. After the pre-hybridzation, the blots were incubated 
with the hybridization solution at 68ºC O/N.  
 
   
  Pre-hybridization/Hybridization solutions (40ml) 
   Formamide   20ml 
   20X SSPE   10ml 
   10X Blocking solution 8ml 
   N-Laurylsarcosine  0.4ml  
   20% SDS   0.04ml  
   deionized water  1.52ml 
   *DIG labeled as RNA  100-200ng/ml 
 
* only for the hybridization solution. 
The first time that the probe was dissolved in the hybridization solution it was heated to 95ºC 
for 5mins. Then the hybridization solution was stored at -80ºC. Thereafter the hybridization 
solution was thawed at 75ºC for 15mins just before use. 
 
After the O/N hybridization the blots were first rinsed under high stringency conditions (2X 
SSC, 0.1% SDS) at RT two times, 5mins each time. Then the blots were washed under low 
stringency conditions (0.1X SSC, 0.1% SDS) two times at 68ºC, 15mins each time. The blots 
were now incubated with the blocking buffer for 30mins. Now the blots were incubated with 
the blocking buffer containing the anti DIG-AP (alkaline phosphatase) conjugated antibody at 
a dilution of 1: 10,000 for another 30mins. Now the blots were washed two times, 15mins 
each time with the DIG washing solution (ref section 3.1.5). The blots were washed briefly in 
the DIG detection solution (ref section 3.1.5). The blots were now incubated with the 
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substrate solution, CSPD for 5mins, then placed in the film cassettes, and are now ready for 
exposures. Exposures were made by placing X-ray films over the blots in the cassettes, and 
after a suitable exposure period, the films were developed using a developer. 
 
3.2.3.8 Analysis of poly (A) tail length: RNA samples were mixed with an equal amount of 
loading buffer (80% v/v formamide and 1mg/ml bromophenol blue in 1X TBE), incubated at 
65ºC for 15mins and loaded onto denaturing polyacrylamide gels (4% w/v acrylamide, 7M 
urea). Running in 1XTBE was performed at about 10V/cms for variable times depending on 
the size of the RNA monitored. Semidry-electroblotting at 200mA for 1hr with 1XTBE as 
buffer was used to transfer the RNAs to a nylon membrane for northern blot analysis. 
Deadenylated transcripts were prepared in vitro by mixing total RNA (10µg) with oligo dTs 
(0.5µg) in a buffer containing 200mM KCl and 1mM EDTA (pH 8.0). The sample was 
incubated at 90ºC for 2mins followed by annealing at 25ºC for 10mins. Then two volumes of 
a solution containing 200mM KCl, 1mM EDTA (pH 8.0), 20mM tris-HCl (pH 8.0), 28mM 
MgCl2, 20 units of RNase inhibitor, and 1 unit of RNase H were added. The sample was 
incubated at 37ºC for 30mins and precipitated with ethanol. 
 
3.2.3.9 Creating density profiles from northern blots: Density profiles can be made for any 
northern blot, using the Aida Image Analyzer v 3.51. The profile gives the distribution of the 
signal intensity over a defined distance. The software requires scanned images of the blots as 
input. Different parameters can be chosen for making the profiles eg. the profiles made in this 
study (fig 18, section 4.3.1) were made by examining the transmisson of light in the scanned 
image. The height and width of the lanes to be analyzed can be set, and the same dimensions 
are then used for all the lanes. 
 
3.2.3.10 Preparation of DIG labeled as RNA probe:  The DIG labeled UTPs (DIG-11-
UTP) were incorporated into an antisense RNA probe spanning a region of the gene of 
interest, which was generated by in vitro transcription using a template generated by 
restriction digestion of a plasmid or a cDNA template containing the gene of interest under 
the control of a T7/T3/SP6 promoter. 
 
  Linearised plasmid template/  1µg  
  cDNA template from RT-PCR 200ngs 
  5X transcription buffer  4µl 
  10mM DIG- (NTP)- mix  2µl 
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  T7 RNA polymerase   2µl (40 units) 
  Deionized water   to 20µl 
 
The transcription was allowed to take place for 2hrs at 37ºC. 20 units of DNaseI was added 
and the mix incubated for 30mins at 37ºC. Then 50µl of the Lithium chloride precipitation 
solution was added followed by 80µl of deionized water and 150µl of cold isopropanol and 
the mixture incubated at -20ºC for atleast 30mins. Then the RNA was spun down at 
15,000rpm, for 15mins at 4ºC. The RNA pellet was then washed with 70% ethanol once again 
at 15,000rpm for 15mins at 4ºC. The pellet was then air dried and resuspended in an adequate 
amount of RNase free water. The concentration of the transcribed RNA was measured and the 
quality of the RNA was then visualized in an agarose gel. 
 
 
3.2.3.11 Molecular Biological techniques used for cloning: 
 
3.2.3.11.1 Restriction Digestion: For any digestion reaction, the amounts of enzyme used or 
the duration of the incubation period would depend on the amount of plasmid DNA to be 
digested. An example of a typical digestion set-up is as is given below:   
 
plasmid DNA  40µg 
Enzyme buffer 30µl 
Restriction enzyme 50 units 
DD water  to 300µl 
 
The reaction mixture was then incubated at a temperature usually 37ºC (with some exceptions 
for some enzymes) for 2-3 hrs. The digestion was checked by running the digested product 
with uncut controls of the same plasmid on a DNA agarose gel. 
 
3.2.3.11.2 CIAP treatment and precipitation of the digested DNA: The digested DNA was 
then dephosphorylated (for cloning purposes) by treatment with Calf intestinal alkaline 
phosphatase (CIAP). Hence 5 units of CIAP was added to the previously digested DNA, and 
the mixture incubated for about 30mins at 37ºC. Now 300µl of phenol-chloroform was added 
to the reaction mix, and the mixture spun at 10,000rpm for 15mins at room temperature (RT). 
The upper aqueous phase was collected. To the organic phase 100µl of 10mM tris pH 7.6 was 
added and the mixture spun once again at 10,000rpm for 15mins at RT. The upper phase was 
collected and pooled with the previously collected aqueous phase. To the collected aqueous 
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phase 300µl of chloroform was added and the mixture spun down at 10,000rpm for 15mins at 
RT. Now the upper phase was once again collected. 30µl of 3M sodium acetate (pH 5.2) was 
added along with 1ml of absolute alcohol and the mixture incubated at -20ºC for at least 
30mins. Now the mixture was spun down at 15,000rpm for 15mins at 4ºC. The supernatant 
was immediately discarded. To the pellet 400µl of isopropanol was added, and spun down 
again at 15,000 rpm for 15mins at 4ºC. The supernatant was discarded and the pellet washed 
one last time with about 400µl of 70% ethanol and finally air dried at 37ºC. The pellet was 
now resuspended in a specified amount of biochemically sterile water, depending on the 
amount of plasmid DNA initially taken-in this case about 60µl. 
 
3.2.3.11.3 Gel extraction of the linearised vector: To the previously purified linearised 
vector DNA, an appropriate amount of the DNA loading buffer was added (30µl to 60µl of 
DNA). A 1% agarose gel was prepared and about 15µl of the Dye-DNA mixture was loaded 
in each of 6 wells. The gel was allowed to run until a good separation of the linearised vector 
from the other fragments resulting from the digestion was achieved. The gel was now 
visualized in a UV transilluminator and neat incisions were made using a scalpel, just behind 
the linearised vector, on the sides and just above. The gel was transferred back to the 
electrophoresis apparatus, which had been previously emptied off the buffer. Now a thin strip 
of preactivated DEAE (diethylaminoethyl) membrane was placed behind the cut piece of the 
gel in close contact with it. Another strip was placed above the cut piece. Now fresh buffer 
was poured into the electrophoresis chamber, and after ensuring that the gel is held tightly in 
place, with the help of a special device, the gel was allowed to run at 80V for exactly 13mins. 
Then the current was turned off, the buffer discarded and the strip of membrane behind the 
piece of gel was removed and placed in a clean eppendorf. About 400µl of the wash buffer 
containing 50mM tris pH 8.0 was added, and after pipetting up and down for a few minutes, 
the wash buffer was discarded and about 600µl of the elution buffer containing 50mM tris pH 
8.0, 5mM EDTA and 1M sodium chloride was added to the membrane in the eppendorf. Now 
the eppendorf was incubated at 74ºC for 1 ½ hrs. Both the buffers had to be brought to RT 
from their storage at 4ºC before use. Now after the incubation 600µl cold isopropanol was 
added to a fresh eppendorf. The elution buffer containing the eluted vector DNA was added to 
this, and the mixture incubated -20ºC for ½hr. The tube was then spun at 15,000rpm for 
15mins at 4ºC. The supernatant was discarded and the pellet was washed with 70% ethanol, 
air-dried and resuspended in an appropriate amount of DD H2O. 
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3.2.3.11.4 Ligation: After the vectors were purified the next step was to determine the 
concentration of the vectors and compare it to the concentration of the inserts and then set up 
a ligation reaction. The ligation reactions were set up taking either a 1:1 or a 1:3 or a 1:5 ratio 
of molar concentrations of the vector: insert as follows: 
               
Vector   50ngs 
   Insert   depends on size of insert 
   Ligation buffer 1µl 
   T4 DNA ligase 1.5µl (7.5 Weiss units)* 
   Deionized water to 10µl 
*0.01 Weiss units will ligate 1µg of DNA in 20mins 
  
The reactions were incubated at 15ºC O/N. 5µl of the ligated mix was used for bacterial 
transformation. 
 
3.2.3.11.5 RT-PCR: For the reverse transcription reaction, the following general protocol is 
followed; 
Total RNA   1µg 
5X RT buffer   4µl 
0.1M DTT   2µl 
10mM dNTPs   2µl 
oligo(dT)s   1µl 
Deionized DD H2O  8.5µl 
RNase inhibitor  1µl (40 units) 
M-MLV reverse   
Transcriptase   0.5µl (100units) 
 
 The reaction mix was then incubated in the thermocycler at: 
   23ºC    10mins 
   37ºC    60mins 







For the PCR reaction the following general protocol was followed: 
  cDNA(RT product)  10µl 
  PCR buffer   9µl 
  50mM MgCl2   1.8µl 
  Sense primer   10pmoles 
  antisense primer  10pmoles 
  deionized water  78µl 
  Taq polymerase  1µl (1.6units) 
 
The reaction mix was overlayed with mineral oil before being placed in the  
Thermal cycler. For each PCR reaction the annealing temperature was chosen  
depending on the melting temperature of the primers. The normal program followed 
was as given below: 
  
 
95ºC    5mins  
 85ºC    5mins (The Taq polymerase was added  
      at this point) 
 95ºC    1min 
 55ºC    1sec    (annealing temperature is varied) 
40X 55ºC    1min     
 72ºC    1sec 
 72ºC    2min 
 
 60ºC    7min 
 4ºC    999min 
     
3.2.3.11.6 PCR: Polymerase chain reactions are designed to amplify a DNA                               
fragment of interest from the input template DNA, which could be either genomic DNA or 
plasmid DNA or cDNA from a reverse transcription. The general protocol for a simple PCR 
reaction would be as given below: 
 
  DNA template   106- 109 molecules  
  10X Taq polymerase buffer 10µl 
  50mM MgCl2   3µl 
  100mM DTT   2µl 
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  10mM dNTPs   2µl 
  sense primer   10pmoles 
  antisense primer  10pmoles 
  DD water   to 100µl 
  Taq polymerase  1µl (1.6units) 
   
 
     The reaction was overlayed with mineral oil and placed in the thermal cycler and  
     the PCR conditions were in general as outlined above for the RT-PCR (section   
     3.2.3.10.5)  
 
3.2.3.11.7 Site directed mutagenesis: The first step was to design appropriate primers with 
the desired mutations. Certain key points had to be remembered while designing the primers: 
 
 
• the melting temperature (Tm) should be as high as 78ºC, to allow for the mismatching. 
• It should be a 44mer 
• two primers were designed- one for the sense strand and one for the antisense strands 
 
    Now the reaction mix was set up as follows: 
  Template DNA (plasmid)  5-50ngs 
  10X Pfu polymersase buffer  5µl 
  10mM dNTPs    1µl 
  sense primer    10pmoles 
  antisense primer   10pmoles   
  deionized water   to 50µl 
  Pfu polymerase   1µl (2.5units) 
       
     All the tubes were overlayed with 30µl of mineral oil. Then the tubes were placed   
     in a thermal cycler and were subjected to the following PCR conditions: 
  95ºC     30 secs 
  95ºC     30 secs     
 12X 55ºC*     1 min 
  68ºC     2 mins/ Kb of plasmid 
 
      The last three steps were carried out for 12 cycles. 
      * Annealing temperature varied depending on the primers 
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      After the PCR, 25µl of PCR products from each reaction was taken in a separate  
      eppendorf and 0.5µl (5units) of DpnI was added to each tube. DpnI has the ability  
      to restrict only methylated DNA. Since the native template strand of the plasmids 
      are methylated, this would leave only the mutated PCR generated plasmid DNA  
      uncut. 3µl of the DpnI digested PCR products were used to transform LK111λ. 
       
3.2.3.11.8 Sequencing: A typical sequencing reaction would include first setting up 
sequencing PCR. 
 
 Plasmid to be sequenced  0.3µg 
 Sequencing primer (sense)  8pmol  
 Deionized water   to 20µl  
 Sequencing premix   6µl 
 
The reaction was overlayed with a small amount of mineral oil.  The PCR conditions were 
as given below: 
  
 Denaturing  96ºC  30secs 
 Annealing  *  15secs 
 Extension  60ºC  4mins 
 
* depends on the melting temperature of the primer. The PCR was done for 25 cycles. 
After the PCR, the probes were transferred to fresh eppendorfs without any mineral oil. 
All the steps that follow were done at room temperature and with HPLC purified water. 
To each probe 80µl of water, and 10µl of 3M sodium acetate (pH 5.2) and 250µl of 100% 
ethanol was added. The samples were spun down at 18,000 RCF(g) for 15mins at RT. The 
supernatants were removed. Now 250µl of freshly made 70% ethanol was added, and the 
samples were spun for 15mins at 18,000 RCF(g) at RT. The supernatants were removed, 
and the pellets were allowed to dry completely. Now 25µl of template suppression buffer 
was added, the tubes vortexed, spun briefly, incubated for 2mins at 95ºC, vortexed spun 
down again. The probes were kept on ice, transferred to sequencing tubes and placed in 
the sequencer.  
 
3.2.3.12 DNA-Microarray-Analysis: The DNA-Microarray-analysis that has been done 
in this study was done in collaboration with PD Dr. Michael Kracht, Dr. Oliver Dittrich-
Breiholz and Ms. Heike Schneider. The Array contains oligonucleotides complementary 
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to about 140 genes that have been chosen for their roles in inflammation and associated 
processes, after an intense survey of literature. To detect differentially expressed genes in 
two different mRNA populations, fluorescently labeled cRNA was generated from 5µg of 
total RNA. The total RNA for this purpose was prepared using the kit described under 
section 3.2.3.1 with an additional DNase I treatment. The labeled cRNA was then 
hybridized O/N at 42ºC to the Array. The following day the array was subjected to a series 
of SSC-stringency washes, dried and scanned using an Affymatrix 428 scanner. The 
resulting data was analyzed using a program provided by the company, MWG Biotech and 









    

















4.1 FEATURES OF AREs REQUIRED FOR mRNA DESTABILIZATION 
AND STABILIZATION BY THE p38 MAPK PATHWAY 
 
AU rich sequences in the 3’UTR of many cytokine and proto-oncogene mRNAs have been 
identified as the cis elements responsible for their rapid degradation. The classical feature of 
AREs is the presence of the pentameric AUUUA motif. Based on the presence or absence of 
the pentamer, their number and organization, Chen and co-workers classified AREs into three 
groups (ref section 2.3.1). Although much work has been done, the salient features of a 
functional ARE have not been obvious especially those features of the AREs that are required 
for mRNA stabilization by the p38 MAP kinase/MK2 pathway. This question was addressed 
by investigating the AU rich sequences of the IL-8 mRNA. 
 
IL-8 is a prototypic human chemokine; chemotactic for leukocytes and involved in 


















Figure 7: IL-8 mRNA organization. The 3’UTR of the IL-8 transcript contains several scattered AUUUA 
motifs, including a group of four (with two of them clustered), starting at position 1050, and one motif in an A- 
and U- rich environment starting at position 1153. A portion of the 3’UTR sequence is shown with the AUUUA 
(ATTTA, since it is a sequence from the genomic DNA) pentamers underlined. Genbank accession no. for IL-8 
is Y00787. 
 
A region in the 3’UTR of IL-8 RNA between nucleotides 972 and 1310 (fig 7), when inserted 
into the 3’UTR of a β-globin RNA, rendered the normally stable β-globin RNA unstable and 
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sensitive to stabilization by the p38 MAPK/MK2 pathway  (Winzen R 1999). The aim of the 
first part of the study was to define the IL-8 ARE and to identify its features required for 
destabilization and stabilization by the p38/MK2 pathway. 
 
4.1.1 The tet-off system: The well-established tet-off system has been used to determine 
mRNA half-lives. In this system the gene of interest is cloned downstream of a tetracycline 
regulated promoter. These constructs are then transiently transfected into a cell line that 
constitutively expresses the tetracycline transactivator (tTA). The addition of tetracycline or 
its analog doxycycline stops transcription. Lysates are made at appropriate time intervals 
thereafter, RNAs prepared and examined in northern blots for half-life determination.  
 
igure 8: Schematic representation of the tet-off system: HeLa tTA cells obtained from Dr.Hermann 
activator 
e 
DNA encoding mRNA of 
interest


















Bujard, constitutively express the tetracycline controlled transactivator (tTA)  (Gossen M 1992). The 
transactivator (tTA) protein is a fusion between the tetracycline repressor (tetR) (from E.coli) and the 
domain of the Herpes Simplex transcription factor (VP16).  The DNA of the reporter gene (as in our case β-
globin) or another gene of interest (like the IL-8 DNA) is cloned under the control of a Tet-responsive promoter, 
which contains sequences for the binding of the tet repressor. The constructs are transfected in the HeLa tTA 
cells. In the absence of tetracycline or its analog doxycycline, tTA binds to and strongly activates the 
transcription of the reporter gene/gene of interest. In the presence of tetracycline/doxycycline the binding of th
tTA to the promoter is abolished and transcription aborted. 
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4.1.2 Evidence for involvement of an ARE in controlling stability of the IL-8 mRNA: 
Earlier results of the lab narrowed down the region in the 3’UTR of the IL-8 gene essential for 
the ARE mediated regulation to the region between nts 972-1132, using the tet-regulated β-
globin mRNAs  (Winzen R 1999). The importance of this region was now confirmed using a 
full length IL-8 mRNA and deletion mutants therein. The full length IL-8 cDNA was 
expressed under a tetracycline-regulated promoter and the stability of the IL-8 mRNA 
monitored using the tet-off system. The half-life of the full length IL-8 mRNA was very short 
under the unstimulated control conditions (Figure 9, upper panel) and was markedly increased 
upon selective activation of the p38 MAP kinase pathway by cotransfection of pCDNA3 
MKK62E, which expresses a constitutively active mutant of MKK6, the upstream activator of 
p38 MAPK. Deletions were then made from the 3’end of the IL-8 cDNA and the stability of 
the mRNAs examined. Deleting about 340nt from the 3’end had no affect on the regulation of 
the stability of the IL-8 mRNA (fig 9, middle panel). However deleting another 250nt, 
including a region encompassing four AUUUA motifs (nt1048-1076), resulted in the 
expression of an IL-8 mRNA with an extended half-life (fig 9, lower panel), which was 
unaffected by the activation of the p38 MAP kinase pathway. Hence the AUUUA- containing 
region appears to play an important role in destabilizing the IL-8 mRNA. As this IL-8 
transcript is still only moderately stable, there may be other instability elements present 
further upstream. Most importantly the mRNA lacking the AU rich region had lost its 
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Figure 9: Evidence for involvement of an ARE in the regulation of IL-8 mRNA stability. HeLa-tTA cells 
were transfected with a vector expressing constitutively active MKK6 (MKK62E) or empty vector (control) and 
with tet-off plasmids encoding the complete IL-8 mRNA (IL-81-1652) and 3’-shortened forms with (IL-81-1310) or 
without (IL-81-1048) a region with four AUUUA motifs (see fig 7). Transcription was stopped by the addition of 
doxycycline (3µg/ml), lysates made at the indicated times, total RNA isolated and analyzed by northern blotting 
on 1% formaldehyde-agarose gels with an IL-8 antisense RNA probe. Ethidium bromide staining of the 28S 
rRNA is shown to allow comparison of the RNA amounts loaded. Results were quantified by a video analyzer 




















4.1.3 Identification of a 60nt regulatory ARE in the IL-8 3’UTR: Further localization of 
the regulatory ARE element in the IL-8 3’UTR was done by inserting fragments (generated 
by RT- PCR) shortened from both ends of the previously identified 160nt fragment (nt 972-
1132) into the 3’UTR of the stable β-globin RNA, and the stability of the expressed mRNAs 
assayed under basal conditions and conditions where pCDNA3 MKK62E had been co-
transfected to activate the p38 MAPK pathway. The results from work done previously and 
those obtained during this study have been summarised  (fig 10A) and show that 
destabilization was lost when shortening from the 3’end deleted the region containing the four 
AUUUA motifs (insertion of nt 972-1048). Shortening from the 5’end resulted in loss of 
regulation even before this region was reached. RNAs expressed from the β-globin reporter 
with an insert of nt 1017-1076 exhibited destabilization and MKK62E induced stabilization 
comparable to the reporter with the insert nt 972-1310 (fig 10B, upper panel). Moreover 
expressing reporter RNAs in which this 60nt fragment between nt 1017-1076 had been 
deleted, increased the basal stability of these mRNA and led to loss of responsiveness to 
MKK62E, characteristics resembling those of a β-globin mRNA with no insertion (fig 10B, 
compare middle and lower panels). The minimal regulatory region within the 3’UTR of the 









































nt 972-1310 + +
nt 972-1200 + +
nt 972-1132 ++
nt 972-1076 ++
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decay and MKK62E-induced stabilization of β-globin-IL-8 hybrid mRNAs (n.d., not determined owing to a long
basal half-life). RNAs were expressed from the plasmids ptetBBB containing the indicated IL-8 sequences 
inserted into the Bgl II site. The AUUUA-containing region is boxed. (B) Comparison of basal decay and 
MKK62E-induced stabilization was performed for β-globin mRNA without insertions or with IL-8 nt 972-13
1017-1076, or 972-1310 with nt 1017-1076 deleted (IL-8972-1310∆). Decay kinetics were analyzed by using a β-
globin antisense RNA probe and quantified as described in the legend to Fig. 9 (triangles, IL-8972-1310; closed 
symbols, control; open symbols, MKK62E). 
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containing domain is sufficient for p38 MAP kinase-induced stabilization:  Structurall
its 3’ part, the nt 1017-1076 fragment has four AUUUA motifs, two of which overlap (fig 
11A). The 5’ part (nt 1017-1047) lacks AUUUA motifs. RNAs expressed from a construct 
containing only the 5’part  (fig 10A, nt 972-1048) were stable, indicating that this region 
cannot destabilize on its own. This region was hence termed the auxiliary domain. Likewi
expressing β-globin RNAs containing the 3’region with the AUUUA motifs, which we now 
call the core domain, resulted in very stable RNAs (fig 11B, upper panel). But because of the
site of insertion in the β-globin construct, this fragment was located directly after the stop 
codon. There have been reports hinting at a possible effect of close proximity to the stop 
codon on the half-life of the expressed RNAs  (Xu N 1997). To discount this possibility, 
RNAs were expressed from a construct in which a suitable spacing between the stop codo
and the core domain was maintained, by inserting a random sequence identical in length to th
auxiliary domain. The half-life of this RNA was examined. This mRNA (IL-8 R-CD)-in 
contrast to the one without spacing- clearly exhibited destabilization, although to a much 
lower extent as compared to that of RNA with the complete ARE (Fig 11B, compare IL-8
CD to IL-8 AD-CD). Thus the spacing between the stop codon and the destabilizing AU- rich
sequence is apparently critical for the functioning of the ARE. Note that lack of 
destabilization of the RNA containing only the auxiliary domain (IL-8 nt 972-10
spacing dependant, as in the case there was a distance of about 50nt between the auxiliary 
domain and the stop codon. Hence taken together, these results indicate that the 5’ auxiliary
domain does not destabilize on its own but enhances the moderate destabilization exerted by 
the core domain. Importantly activating the p38 MAP kinase cascade by co-transfecting 
pCDNA3 MKK62E, resulted in further stabilization of the RNA containing the random 
sequence plus the core domain (IL-8 R-CD Fig 11B). Thus, the AUUUA motif-containi
core domain is sufficient to confer sensitivity to p38 MAP kinase-induced stabilization.  
Further, replacing every 10nt in the 5’, central, or 3’ part of the auxiliary domain with a 1
random sequence indicates that the sequences most crucial for enhancing destabilization are 













A auxiliary domain core domain
 
IL-8 ARE                            1048 
                                                       I
1017-cauaaauuauuuucaaguguaacuuauuaac-cuauuuauuauuuauguauuuauuuaagc-1076
R31  gcauagcgucgccgccucgagauaccggacc-cuauuuauuauuuauguauuuauuuaagc-1076                                                     









igure 11: Two-domain structure of the IL-8 ARE. (A) Sequence of the IL-8 ARE as shown with AUUUA 
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Basal decay and MKK62E-induced stabilization were analysed for β-globin mRNAs with domains of IL-8 AREs 
as indicated (CD, core domain; AD, auxiliary domain; R, random sequence; triangles IL-8 R-CD; closed symbol, 
control; open symbols MKK62E). (C) Destabilizing activity of the IL-8 ARE (IL-8AD-CD) and derivatives in which
the auxiliary domain was mutated by exchanging 10nt of its 5’ part (IL-8AD(R1-10)-CD), its central part (IL-8AD(R11-
20)-CD), or its 3’ part (IL-8AD(R21-30)-CD) with a random sequence (GCCGCCUCGA). mRNA stability was assayed 
and quantified as described in the legend to fig 9. 
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4.1.5 mRNA stabilization by HuR is selective and can be imposed by a distinct auxiliary 
domain: Experiments from the group show that an ARE binding protein, HuR interacts with 
both the IL-8 and GMCSF AREs in gel shift assays  (Winzen R 2004). It has been shown by 
several groups that HuR binds to and stabilizes ARE-containing RNAs (ref section 2.3.1.1.1). 
There have also been some reports claiming a role for HuR in p38 MAPK/MK2 mediated 
stabilization of ARE-containing RNA  (Atasoy U 2003),  (Tran H 2003). Hence the role of 
HuR in the p38/MK2 pathway induced mRNA stabilization was investigated. Overexpression 
of myc-tagged HuR, in HeLa tTA cells cotransfected either with ptetBBB IL-81017-1076 ( ref 
section 4.1.3), ptetBBB GMCSF or ptetBBB c fos, the latter two expressing β-globin RNA 
containing either the GMCSF ARE  (Winzen R 1999) or the c fos ARE, revealed that 
degradation of the IL-8 ARE-containing RNA was not affected by overexpression of myc-
tagged HuR (Fig 12A, upper panel). Whereas clear stabilization was observed for the RNA 
containing the ARE of GMCSF, and-in line with the observations of others  (Chen CY 2002)- 
even stronger stabilization occurred for an RNA containing the c fos ARE (fig 12A, middle 
and lower panels). Thus the inability of HuR overexpression to stabilize an IL-8 ARE 
containing reporter suggested that HuR does not account for the p38 MAPK/MK2 effect on 
mRNA stability. 
 
Since our own results and those of Shyu and co-workers  (Chen CY 1994) indicate that all the 
above mentioned AREs have bipartite structures with auxiliary and core domains, we asked if 
the differences in HuR induced stabilization as opposed to p38/MK2 induced stabilization 
were dependant on particular domains. Constructs were made in which the auxiliary domain 
of the IL-8 ARE was replaced with those of the GMCSF ARE or the c fos ARE. The RNA 
containing a chimeric ARE with the auxiliary domain of the GMCSF ARE fused to the core 
domain of the IL-8 ARE was stabilized significantly by HuR overexpression (Fig 12B, upper 
panel). Even stronger stabilization was observed for the RNA containing the IL-8 core 
domain fused to the auxiliary domain of the c fos ARE (Fig 12B, lower panel). This domain 
lacks AUUUA motifs and was recently identified by Shyu and co-workers as the major 
domain responsible for HuR induced stabilization in the c fos ARE  (Chen CY 2002). Thus, 
unresponsiveness of the IL-8 ARE to HuR-induced stabilization results from the lack of a 
HuR-responsive auxiliary domain. These results show different sequence requirements for 
stabilization by HuR as opposed to that due to p38MAPK/MK2 activation.  
 
This hypothesis was further substantiated by some co-transfection studies. RNAs containing 
the c fos auxiliary domain fused to the IL-8 ARE core domain were stabilized by the 
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expression of MKK62E (Fig 12C). While this effect-expectedly- was inhibited by the co-
expression of a dominant negative form of MK2 (MK2K76R), stabilization by the 
overexpression of HuR was not. This rules out the possibility that MK2 is involved in the 
effect of HuR. This and the involvement of different ARE domains in each of the two effects 
indicate that stabilization of ARE-containing mRNAs by HuR overexpression and that by p38 
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Figure 12: mRNA stabilization by HuR is selective and can be imposed by auxiliary domains. β-globin 
mRNAs containing the ARE of IL-8, GM-CSF or c fos (A) or chimeric AREs consisting of the core domains of 
the IL-8 ARE and the auxiliary domain of the GM-CSF or c fos AREs (GM-CSFAD-IL-8CD or fosAD-IL-8CD, 
respectively) (B) were co-expressed with empty vector or myc-HuR as indicated. (C) Cells were transfected with 
plasmids encoding the β-globin – fosAD-IL-8CD mRNA and myc-HuR or MKK62E together with empty vector 
or an expression vector for MK2K76R. mRNA stability was determined and quantified as described in the 












4.2 ROLE OF THE POLY (A) TAIL IN mRNA DEGRADATION AND 
ITS REGULATION BY THE p38 MAPK PATHWAY 
 
Deadenylation is considered the first step in the degradation of ARE-containing mRNAs (ref 
section 2.3.1). The p38/MK2 pathway can therefore stabilize ARE-containing RNA either by 
affecting deadenylation or by affecting later stages in the mRNA degradation machinery. In 
this part of the work, this question has been addressed.  
 
4.2.1. Oligo(dT)/RNase H- Northern Assay: In order to determine differences in poly (A) 
tail lengths, the Tet-off system has been used in combination with a method involving RNase 
H digestion of total RNA to generate deadenylated reference RNA. RNase H has the ability to 
recognize RNA: DNA hybrids and cleave the RNA part of the hybrid. Total RNA prepared 
from eukaryotic cells is treated with RNase H in the presence or absence of oligo(dT)s. The 
oligo(dT)s hybridize to the poly (A) tail of the poly (A) tailed mRNA population, the RNase 
H recognizes these RNA: DNA hybrids and cleaves the RNA portion i.e the poly (A) tail 
leaving behind deadenylated RNAs (fig 13). These deadenylated RNA species prepared in 
vitro are compared to full-length mRNAs with poly (A) tails in a high-resolution gel. Total 
RNA when analyzed under these conditions and compared to the single band representing the 
deadenylated RNA marker, appears as a smear representing mRNAs captured at different 
stages of deadenylation. Hence the gradual disappearance of the longer polyadenylated 































































Figure 13: Schematic representation and an experimental example of the oligo (dT)-RNase H 
digestion/northern assay to compare poly (A) tail lengths. Total RNA from cells transfected with ptetBBB 
GMCSF was mixed with oligo(dT)’s and the annealing was carried out at 25ºC. Ribonuclease H (RNase H) was 
then added and the digestion done at 37ºC for 30mins, following which the digested RNA was precipitated and 
examined along with an aliquot of undigested RNA on 1.4% formaldehyde-agaorose gel by northern blotting 
with a β-globin antisense RNA probe.  
 
 
4.2.2 Use of denaturing polyacrylamide gels allows a finer resolution of poly (A) tail 
lengths: Although the differences between polyadenylated and deadenylated RNAs were 
visible on the 1.4% agarose gels, the resolution was not sufficient to make statements 
concerning rates of deadenylation. Denaturing polyacrylamide gels have been used routinely 
in molecular biology to visualize short RNA fragments generated in vitro. There have been 
other reports where these systems have been used to observe differences in the 
polyadenylation state  (Decker CJ 1993),  (Salles FJ 1999).  
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A protocol was thus generated based on these reports and optimized to suit our requirements. 
4% acrylamide/7M urea gels were used. The RNAs from the gels were blotted onto nylon 
membranes by semi-dry electroblotting. A more detailed version of the protocol can be found 
under the ‘Methods’ chapter (ref section 3.2.3.8). RNAs were prepared from HeLa tTA cells 
transfected with ptetBBB c fos and examined on denaturing acrylamide gels. The separation 
that was achieved using the acrylamide system was far better than that obtained using the 
 
agarose gels (fig 14). 
igure 14: An experimental example of the resolution achieved using denaturing acrylamide gels.  HeLa 
sfected with ptetBBB c fos. Transcription was stopped by the addition of doxycycline, lysates 




tTA cells were tran
were prepared at the indicated time intervals, RNAs extracted and analyzed by northern blotting on 
4%acrylamide/7M urea gels with a β-globin antisense RNA probe. Deadenylated standard prepared by RNase H 
treatment is shown (p(A)-). 
 
.2.3 Activation of the4
containing β-globin RNA: The high resolution denaturing poly acrylamide gels were then 
used to examine differences in the poly (A) tail length of the β-globin reporter RNA having 






































Figure 15: p38 MAPK activation inhibits the deadenylation and degradation of an IL-8 
62E (MKK62E). The 
 
he degradation and deadenylation of the IL-8 ARE-containing β-globin RNAs was much 
n time 




o the polyadenylation signals AAUAAA in the constructs ptetBBB and ptetBBB GMCSF 
 
ARE-containing β-globin RNA. HeLa tTA cells were transfected with ptetBBB  
IL-8972-1310 and cotransfected with either an empty vector (control) or with pCDNA3 MKK
next day transcription was stopped by the addition of doxycycline. Short time intervals of 20 mins were chosen
for the unstimulated controls in contrast to the longer kinetics for the stimulated cells. RNAs were prepared, run 
alongside deadenylated BBB IL-8972-1310 RNAs on the denaturing polyacrylamide gels (p(A)-) and analyzed by 




slower in the cells where the p38 MAP kinase pathway had been activated, taking into 
account the longer kinetics for lysate preparation in the latter (fig 15, compare the 80mi
point in the left panel with the 240min in the right). Thus the activation of the p38 MAPK 
pathway appears to inhibit the rapid deadenylation of ARE-containing mRNA.  
 
4
approach to investigating the importance of the poly (A) tail and associated proteins in A
mediated mRNA degradation would be to generate ARE-containing RNAs without a poly (A
tail and then analyze ARE-dependant regulation of mRNA stability. Histone mRNAs are the 
only known eukaryotic mRNA that do not end in a poly (A) tail. Instead they end in a 
conserved stem loop that acts as a functional replacement of the poly (A) tail, participa
the export, stability and translatability of these mRNA. Hence the introduction of the histone 
stem loop (HSL) into the 3’UTR of the β-globin RNA in the plasmids ptetBBB and ptetBBB 
GMCSF would generate a functional RNA without a poly (A) tail, enabling us to look at 
mRNA degradation in the presence and absence of the poly (A) tail. 
 
S
were destroyed by site directed mutagenesis, simultaneously generating an Ava III restriction
site (fig 16). A region of the histone H1.3 mRNA, that included the 15bp histone stem loop 
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(HSL), the histone downstream element- a purine-rich sequence 9-14nt 3’ of the cleavage sit
and flanking sequences  (Cotten M 1988),  (Mowry KL 1989),  (Neu-Yilik G 2001) was 




 ptetBBB GMCSF. Two bases of the 
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Cloning of the histone stem loop into ptetBBB and
olyadenylatio
signal in the plasmids, ptetBBB and ptetBBB GMCSF, were mutated to create an Ava III restriction site 
(ATGCAT) by site directed mutagenesis using the QuikChangeTM kit from Stratagene. A 967bp fragment from
the histone H1.3 gene was PCR amplified from genomic DNA isolated from HeLa cells and cloned into th
newly generated Ava III sites in the plasmids ptetBBB and ptetBBB GMCSF to create the plasmids 
ptetBBBmHSL and ptetBBBmGMCSF HSL. The Bgl II site in the plasmid ptetBBB into which ARE sequences 




expressed from these plasmids for the presence or absence of a poly (A) tail. It was clear fro
the results that the RNA expressed from these constructs ran as a single band, in contrast to 
the smear representing a heterogenous population of mRNAs with varying poly (A) tail 
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lengths for polyadenylated RNA. Also the band remained unchanged after oligo(dT)-RN
digestion (fig 17A). The half-lives of these mRNA without a poly (A) tail were then analyzed 
for destabilization by an ARE and alterations in the presence or absence of p38 MAPK 
activation. In the presence of the poly (A) tail, the GMCSF ARE-containing β-globin RN
rapidly degraded when compared to the β-globin RNA without an insert and stabilized by 






2E expression (fig 17B). In the absence of t
poly (A) tail for the RNAs with the histone stem loops, the half-life of the GMCSF ARE-
containing RNA becomes comparable to that of the β-globin RNA without an insert and 
unresponsive to p38 MAPK activation (fig 17B). Hence the ARE-dependant regulation o
mRNA stability appears to be lost in the mRNAs without a poly (A) tail. This result sugges
a role for the poly (A) tail and its associated proteins in ARE-dependant rapid mRNA 
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Figure 17: Loss of ARE-dependant regulation in the 
absence of a poly (A) tail. (A) Absence of a poly (A) tail in 
mRNAs containing a histone mRNA-derived stem loop was 
confirmed by polyacrylamide gel electrophoresis of total 
RNA from cells expressing β-globin RNAs with the 
GMCSF ARE with the poly (A) tail (An) or with the histone 
stem loop (h-sl) before and after digestion with RNase H 
plus oligo(dT). (B) Decay kinetics was determined for 
polyadenylated and nonadenylated, histone stem loop 
containing β-globin RNAs without or with the GMCSF 
ARE. Basal decay and MKK62E-induced stabilization were 
assayed as described in the legend to fig 9.
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4.3 UV LIGHT AND mRNA STABILITY 
 
Work done in our group indicated that like activation of the p38 MAP kinase/MK2 pathway, 
exposure to UV-B light led to an inhibition of mRNA degradation  (Bollig F 2002). Unlike 
the p38 MAPK/MK2 pathway whose effect is limited to AU-rich transcripts and 
independently of it, UV light stabilizes short-lived mRNAs either containing or lacking AU-
rich elements. The signaling involved in the effect of UV-light, and the effect of UV light on 
mRNA deadenylation, have been addressed in this part of the work. 
 
4.3.1 Effect of UV-B on mRNA degradation and deadenylation: Since UV light inhibits 
mRNA degradation; we asked if this inhibition of degradation was accompanied by an 
inhibition of deadenylation. Two mRNA species were expressed in HeLa tTA cells using the 
tet-off system: the β-globin reporter with the c fos ARE and the TIMP1 mRNA which lacks 
ARE sequences in its 3’UTR and contains a short insertion of the CAT gene in its 5’UTR to 
distinguish it from endogenous transcripts. RNAs were prepared from cells exposed to UV-B 
and also from cells in which the ptetBBB c fos constructs had been cotransfected with ptet 
myc-HuR, which expresses the well-known RNA binding protein-HuR. HuR has been 
described in the literature as an ARE binding protein (refer section 2.3.1.1.1), shown to be 
involved in stabilization of c fos ARE-containing β-globin RNA in overexpression studies, 
but without causing any inhibition of the process of deadenylation  (Peng SS 1998). Moreover 
HuR was also shown to be involved in the UV-C mediated stabilization of p21 mRNA  (Wang 
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Figure 18: Effect of UV-B on mRNA degradation and deadenylation. HeLa tTA cells were transfected 
with (A) petBBB c fos and empty vector (control) or ptet-myc HuR (HuR), and (B) pUHD10 CAT TIMP1. 
Following the transfection, the cells were split into parallel cutures in 25cm2 flasks. The next day, one set of 
these cultures was exposed to 1200 J/m2 of UV-B (UV) and after 2hrs at 37ºC, transcription was stopped by the 
addition of doxycycline, total RNA isolated and examined on 4% denaturing polyacrylamide gels as described in 
the legend to fig 14. Density profiles made using the Aida Image Analyzer v 3.51 are shown below (A) (ref 








Exposure to UV light caused a strong inhibition of both the degradation and the 
accompanying deadenylation of the c fos ARE-containing β-globin reporter and the non-ARE 
containing CAT TIMP1 reporter RNA (fig 18A and B). This contrasted to the stabilization 
imposed by the overexpression of HuR, where there was an inhibition of degradation with 
only a marginal effect on the process of deadenylation (fig 18A middle panel). While this 
effect of HuR on deadenylation coincided with the observations of Peng et al.  (Peng SS 1998) 
this result argues against the involvement of HuR in the UV effect. 
 
4.3.2 Effect of other cell stresses on mRNA degradation and deadenylation: The effect of 
UV light on mRNA degradation and deadenylation could be specific to UV light or may be a 
phenomenon common to other cellular stresses. Hence the effects of other cellular stresses 
like heat shock on both ARE and non-ARE containing reporters were examined. Three 
different heat shock temperatures, 40ºC, 42ºC, and 44ºC, were tested using the c fos ARE-
containing β-globin reporter. There was clearly a temperature dependant increase in the 
inhibition of the degradation and deadenylation of the c fos ARE containing β-globin RNA, 
with the maximum inhibition at 44ºC (fig 19A). Hence all other heat-shock experiments were 
performed at 44ºC. As was seen in the case of UV light, heat shock at 44ºC also led to a 
strong inhibition in the degradation and deadenylation of the non-ARE containing CAT 
TIMP1 transcripts (fig 19B). Thus like UV light, heat shock at 44ºC led to a generalized RNA 
stabilization of both ARE and non-ARE containing reporter transcripts, whether by a similar 
mechanism or via activation of the same signaling pathways remains to be seen.  
 
The effect of another direct cell stress-osmotic stress on mRNA metabolism was then 
examined. There was an inhibition in the degradation and deadenylation of both the ARE and 
non-ARE containing reporters but to a lesser extent as compared to both UV light and heat 
shock, indicating that perhaps different cellular stresses affected mRNA degradation to 
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Figure 19: Effect of heat shock and osmotic shock on mRNA degradation and deadenylation. HeLa tTA 
cells were transfected with ptetBBB c fos or pUHD10 CAT TIMP or both as indicated. The transfected cells 
were kept at 37ºC (control) or exposed to the indicated heat shock temperatures for 1hr (A) and (B) or 500mM 
sorbitol applied to the transfected cells for 30mins at 37ºC and washed away with warm PBS (C). Transcription 
was stopped by the addition of doxycycline. Degradation and deadenylation kinetics was then determined as 




The effects of two other cellular stresses - H2O2 and γ radiation on mRNA stability were then 
checked. While the application of H2O2 would lead to the release of Reactive Oxygen Species 
(ROS) within the cells, exposure to γ radiation would lead to DNA damage. Hence by 
examining the effects of these two cellular stresses on mRNA stability, the involvement of 
pathways that are activated either by ROS or by DNA damage, in the inhibition of mRNA 
degradation and deadenylation by UV light can be examined (ref discussion). The results 
show that there was no effect of all three doses of γ radiation tested, on mRNA degradation 
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and deadenylation (fig 20 right panel). But exposure to H2O2, had an effect that was similar to 
UV light in terms of the inhibitions of both mRNA degradation and deadenylation (fig 20 left 
panel). These results indicate that ROS may be involved in the effect of UV light and argue 
against the involvement of DNA damage in the inhibition of mRNA degradation and 
deadenylation by UV light (more in discussion). 
 
 
igure 20: Effect of H2O2 and γ-radiation on mRNA degradation and deadenylation. HeLa tTA cells 
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were co-transfected with ptetBBB c fos and pUHD10 CAT TIMP and the transfected cells left untreated 
(control) or exposed to the indicated doses of γ radiation or to 1mM H2O2 for either 10mins or 20mins. The 
stressed cells were allowed to recover for 1/2hr at 37ºC before stopping transcription with doxycycline. 




antioxidants like N-acetyl cysteine (NAC) or butylated hydroxy anisole (BHA) or enzymatic 
antioxidants like catalase to inhibit ROS generation and effects induced by exposure to H2O2  
(Peus D 1999) has previously been documented. Hence such antioxidant pre-treatment would 
enable us to clarify the involvement of ROS in UV light mediated mRNA stabilization. HeLa 
tTA cells were therefore subjected to a pretreatment with both- NAC and BHA and then 
exposed to UV-B or H2O2. The results indicate that a combined pre-treatment with NAC 
BHA could partially inhibit the H2O2 mediated increase in mRNA stability but had no effect 




igure 21: Use of antioxidants to investigate the involvement of ROS in UV mediated mRNA 
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stabilization. HeLa tTA cells were transfected with ptetBBB c fos, and left untreated (no treatment) o
to UV-B or treated with 0.5mM H2O2 without or with prior treatment to 30mM NAC and 100µM BHA for 1/2hr
or as control, treated only with both antioxidants. Transcription was stopped by the addition of doxycycline. 






containing β-globin reporter RNA, followed by exposure to UV-B and H2O2 showed that
the antioxidants-NAC and BHA, the effect of H2O2 on mRNA degradation and deadenylation 
could be partially inhibited. But the UV-mediated inhibition of both these processes could not 
be blocked by catalase expression (fig 22). This confirms that ROS may not be directly 
involved in the effect of UV light but is rather suggestive of a scenario wherein these tw
cellular stresses exert their effects on mRNA turnover independently, perhaps through 
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Figure 22: Effect of catalase expression on UV- mediated inhibition of mRNA degradation and 
h 
ined 







deadenylation. HeLa tTA cells were transfected with ptetBBB cfos and empty vector or with pCDNA3 
catalase, and the transfected cells left untreated or exposed to UV-B or to 0.5mM H2O2 where indicated. 
Transcription was stopped by the addition of doxycycline and degradation and deadenylation kinetics determ




UV light activates several signaling cascades including the p38 MAP kinase pathway. Our 
results with the transcript selectivity of the two modes of stabilization indicated that the p38
MAP kinase pathway might not be involved in the UV mediated stabilization of mRNA. 
Although stabilization of mRNA by UV light had been shown previously to be independe
p38 MAPK activation  (Bollig F 2002), inhibition of mRNA deadenylation could still be a 
consequence of this activation. Hence SB 203580, the p38MAPK inhibitor was applied to th
cells prior to UV exposure or heat shock and the effects on mRNA deadenylation examined. 
Blocking the p38 MAP kinase activation using the SB inhibitor could not reverse the 
inhibition of mRNA degradation and deadenylation induced by both UV light and by h
shock (fig 23). These results corroborate earlier results and rule out the requirement of prio





igure 23: The effect of UV light on mRNA deadenylation and degradation does not require activation 
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of the p38 MAPK. HeLa tTA cells were transfected with ptetBBB c fos. The transfected cells were either left 
untreated, or incubated with 2µM SB 203580 for 30 mins, exposed to UV-B or heat-shocked at 44ºC without or 
with a 30mins pre-incubation in the presence of the SB inhibitor. Transcription was stopped with doxycycline. 




inhibit general protein synthesis: mRNA stabilization is normally expected to increase 
mRNA levels and thereby increase protein synthesis. On the other hand exposure to UV li
inhibits general protein synthesis  (Wu S 2002),  (Deng J 2002). Results from the group 
showed that significant inhibition of protein synthesis occurred only after exposure to 24
J/m2 of UV light  (Beniam 2003). HeLa tTA cells were exposed to different doses of UV ligh
and the effects on mRNA degradation and deadenylation examined to see whether the effects 
of UV light on translation and mRNA stabilization required different doses of UV light. 
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UV-induced stabilization and inhibition of deadenylation correlated and were maximal 
already at 600 J/m2 (fig 24), a dose that is 4 fold lower than the dose of UV light at which 
effects on protein synthesis were observed. Thus mRNAs stabilized at low doses of UV light 
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Figure 24: mRNA deadenylation and degradation are inhibited by low doses of UV light. HeLa tTA cells 
were transfected with ptet BBB c fos and the transfected cells exposed to different doses of UV light as 
indicated. Transcription was stopped by the addition of doxycycline. Degradation and deadenylation kinetics was 
determined as described in the legend to fig 14. 
 
 
4.3.6 UV light inhibits the degradation and deadenylation of the endogenous IL-8 
mRNA: The effects of UV light on the stability of the endogenous IL-8 mRNA had 
previously been examined and documented  (Beniam 2003) by our group. Hence we analyzed 
the effects of UV light on the deadenylation of the IL-8 mRNA. In the HeLa cells IL-8 
production can be induced by exposure to the pro-inflammatory cytokine, IL-1. The poly (A) 
tail length distribution during induction was analyzed using the acrylamide gels. In 
accordance with previous results the induction was transient, with a sharp peak at 1hr after the 
addition of IL-1, and gradual disappearance of the RNA thereafter. At the 1hr time point when 
the IL-8 mRNA was freshly transcribed; most of the mRNA was highly polyadenylated (fig 
25). By 2hrs post-IL-1 addition, an even distribution of poly (A) tail lengths was seen. At 
4hrs, when most of the IL-8 mRNA was degraded, the shorter oligo-adenylated and largely 
deadenylated species were more prominent, attesting to the rapid degradation and 




























Figure 25: Induction of IL-8 mRNA in HeLa cells by IL-1. 1ng/ml of IL-1 was added to HeLa tTA cells in 
culture. Lysates were made at the indicated times, RNAs prepared and analyzed by northern blotting on 
acrylamide gels using an IL-8 antisense RNA probe. An aliquot of the total RNA from the 1hr time point was 
digested with RNase H to prepare the deadenylated refernce p(A)-. 
 
Deadenylation of the IL-8 mRNA following exposure to UV light was then analyzed in an 
actinomycin D chase experiment. In the absence of exposure to UV light, the  
IL-8 mRNA was rapidly deadenylated (fig 26 left panel). Exposure to UV light after the 
addition of IL-1caused a prolonged inhibition in both the degradation and deadenylation of 
the IL-8 mRNA (fig 26 middle panel). Even when the cells were exposed to UV light prior to 
IL-1 stimulation, the effect of UV light on the inhibition of mRNA degradation and 
deadenylation could be reproduced (fig 26 right panel). This last experiment indicated that the 
effect of UV light on mRNA degradation and deadenylation was not via any direct 
modification of the RNAs themselves, as under these experimental conditions the IL-8 RNAs 
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Figure 26: Effect of UV light on the deadenylation and degradation of the endogenous IL-8 mRNA. 
HeLa cells were stimulated with 1ng/ml of IL-1 without (IL-1) or with exposure to UV-B, 1hr after (IL-1→UV) 
or 1hr before (UV→IL-1) the addition of IL-1. 3hrs after the addition of IL-1 transcription was stopped by the 
addition of 5µg/ml of actinomycin D, a general transcription inhibitor. Degradation and deadenylation kinetics 




Exposure to UV light causes the transcriptional induction of several stress response genes. To 
test whether the effect of UV light on mRNA degradation requires the transcriptional 
induction of gene expression, transcription was stopped by the addition of actinomycin D 
immediately after the exposure to UV light. As the inhibition of mRNA degradation and 
deadenylation proceeded unabated under these conditions (fig 27), these results indicate that 






















Figure 27: Effect of UV light is independent of ongoing transcription. HeLa tTA cells were stimulated 
with IL-1 for 3hrs, exposed to UV-B and 5µg/ml actinomycin D added immediately to stop transcription. 
Degradation and deadenylation kinetics was determined as described in the legend to fig 14 with an antisense IL-
8 RNA probe. 
 
4.3.7 UV light stabilizes other short-lived mRNA transcripts involved in the 
inflammatory response: The effects of UV light on the IL-8 mRNA suggested a role for 
mRNA stabilization by UV light in the inflammatory response. This hypothesis was examined 
by analyzing the effects of UV light on the stability of mRNAs on a larger scale using the 
microarray facility at the Institute of Molecular Pharmacology, Hannover Medical School in 
collaboration with PD. Dr. Michael Kracht and Dr. Oliver Dittrich-Breiholz. This microarray 
contains oligonucleotides complementary to about 140 mRNA that have been chosen for their 
roles in inflammation and associated processes. The effects of UV light on the mRNA of 
these genes from HeLa tTA cells was determined by comparing the differences before and 
after the addition of actinomycin D with and without exposure to UV-B. The reproducibility 
of the results was confirmed by doing a second experiment. Selected genes whose expression 
is regulated by UV light at the level of mRNA stability are shown in the table. Of all the cells 
types in our body, the epidermal keratinocytes are maximally exposed to UV light. Several 
studies involving effects of UV light are carried out using primary keratinocytes or 
keratinocyte cell lines like the HaCaT cells  (Chen W 2001),  (Ashida M 2003). Therefore 
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mRNA from HaCaT cells were also analysed on the same microarrays. The profiles obtained 
overlap with those obtained using the HeLa cells. 
 
Since all the genes on the array have crucial roles to play in inflammation and related process, 
the regulation of the mRNA stability of a group of these genes by UV light indicates that this 




















3h act D 
HeLa tTA 
2hIL1→UV 









3h act D 
Fold 
Stabilization 
NM_0 20529 nfkbia 3 18 5.9 3 20 6.6 
NM_0 00600 il6 14 75 5.5 17 66 3.8 
NM_0 03467 cxcr4 7 28 3.8 8 37 4.7 
NM_0 00584 cxcl8 18 71 4.0 24 64 2.7 
NM_0 01165 birc3 20 64 3.2 18 53 2.9 
NM_0 02228 jun 20 41 2.0 6 35 5.5 
NM_0 02923 rgs2 16 33 2.0 11 42 3.9 
NM_0 21009 ubc 27 61 2.3 32 70 2.2 
NM_0 00963 ptgs2 25 72 2.8 44 66 1.5 
NM_002729 hhex 28 45 1.6 16 42 2.6 
NM_0 06290 tnfaip3 23 34 1.5 14 36 2.5 
NM_0 02229 junb 31 38 1.3 18 34 1.9 
NM_0 15675 gadd45b 45 61 1.3 34 46 1.4 
2nd experiment Ist experiment 
 
 
TABLE 2: Examination of UV-dependant stabilization of mRNA on a large scale using an 
inflammatory microarray. HeLa tTA cells were stimulated with 1ng/ml of IL-1 for 2hrs, and 
transcription stopped by the addition of actinomycin D with and without a subsequent exposure to  
UV-B. Lysates were made 3hrs later and RNAs were prepared for microarray analysis as outlined in 
methods section 3.2.3.1. The results shown were calculated from the raw data and expressed as the 
percentage of RNA left in the cytoplasm after the addition of actinomycin D with and without UV 
exposure. The fold stabilization by UV exposure is also shown. The table shows results from two 
independent experiments, for a group of transcripts, which were selected using certain criteria: the 
transcripts selected had to have short half-lives (% of RNA left after act D addition should be less than 
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2hIL1→UV 





3h act D   
HaCaT 
2hIL1→UV 
3h act D 
Fold 
Stabilization 
NM_0 00584 cxcl8 13 59 4.4 12 52 4.5 
NM_0 00576 il1b 16 71 4.5 15 63 4.2 
NM_0 02228 jun 9 27 3.0 6 36 6.4 
NM_0 00758 csf2 32 83 2.6 13 73 5.5 
NM_0 20529 nfkbia 6 15 2.4 5 20 4.3 
NM_0 21009 ubc 18 55 3.0 25 74 2.9 
NM_0 00575 il1a 19 41 2.1 13 41 3.1 
NM_0 06290 tnfaip3 21 32 1.5 16 29 1.9 
NM_0 02198 irf1 32 39 1.2 16 29 1.9 
2nd experiment Ist experiment 
 
 
TABLE 3: The effect of UV light on the stability of mRNA from HaCaT cells. HaCaT cells (see 
section 3.1.11) were stimulated with 1ng/ml of IL-1 for 2hrs, and transcription stopped by the addition 
of actinomycin D with and without a subsequent exposure to UV-B. Lysates were made 3hrs later and 
RNAs were prepared for microarray analysis as outlined in methods section 3.2.3.1. The results have 



























5  DISCUSSION: 
 
In this study different aspects of two different kinds of regulated mRNA turnover have been 
examined: the p38 MAPK/MK2 dependant stabilization of ARE-containing mRNA and the 
UV-B dependant stabilization of ARE and non-ARE containing mRNA. Both kinds of mRNA 
stabilization are activated by inflammatory/stress signals and contribute to the expression of 
genes involved in inflammation like the cytokine genes.  
 
5.1 Structural and functional analysis of the IL-8 ARE: In the first part of the study, the 
AU-rich element of the IL-8 mRNA was characterized. AU-rich sequences present in the 
3’UTR of the IL-8 mRNA have been shown to be involved in the post-transcriptional control 
of its expression  (Winzen R 1999). While previous studies demonstrated this using the β-
globin reporter expressed with the tet-off system, the importance of AU-rich sequences for 
regulating IL-8 mRNA stability has been now confirmed, using full-length and truncated IL-8 
RNA constructs (fig 9). The destabilizing potential of AU-rich sequences has for the most part 
been attributed to the presence of one or more AUUUA motifs. However it has been observed 
that an AUUUA motif-containing region alone was of low destabilizing potential  (Chen CY 
1994),  (Xu N 1997),  (Winzen R 1999),  (Yu Y 2001). Defining features of the IL-8 ARE 
required for regulated mRNA stability, we report the importance of a 30nt flanking sequence, 
which enhances the moderate destabilizing potential exerted by the AUUUA-motif containing 
region of the IL-8 ARE.  
 
The minimal regulatory element in the IL-8 3’UTR is thus a 60nt region with a bipartite 
structure, having an AUUUA containing sequence-the core domain and a 30nt upstream AU-
rich sequence termed the auxiliary domain (fig 10 and 11). A similar structure has been 
reported for the ARE of c fos although in this case the U-rich auxiliary domain is 3’ to the 
AUUUA motif containing core domain  (Chen CY 1994). On the other hand studies from this 
lab and others showed that the GMCSF ARE is organised like the IL-8 ARE containing 
clusters of overlapping AUUUA motifs in the 3’part and AU-rich sequences 5’ to the 
AUUUA motifs that contribute to destabilization  (Winzen R 2004),  (Xu N 1997). Although 
the existence of auxiliary domains has not been explored for many AREs, evidence has been 
presented that additional sequences outside the AUUUA motif-containing region, which may 
be functional equivalents of such auxiliary domains, are necessary to observe the rapid 
degradation exerted by the AREs. These may be present either upstream as in the TNF-α 
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mRNA   (Stoecklin G 2001) or downstream as in the COX-2 mRNA  (Lasa M 2000). Hence 
the organisation of these domains in AREs appears to vary.  
 
Although much work has been done characterizing features of AREs that are required for 
degradation, few other studies have characterized the sequence features of AREs, which 
determine the control of its function by signaling pathways. While the auxiliary domain of the 
IL-8 ARE is necessary to enhance destabilization exerted by the IL-8 ARE core domain, it is 
dispensable for the stabilizing effect of the p38/MK2 pathway (fig 11). This potential of 
auxiliary domains to enhance destabilization exerted by the AUUUA-motif containing core 
domain becomes particularly important in the event of mutations destroying the individual 
AUUUA motifs  (Winzen R 2004),  (Chen CY 1994). The minimal functionally relevant ARE 
motif has been variously defined as UUAUUUA(A/U)(A/U) or the nonamer UUAUUUAUU  
(Lagnado CA 1994),  (Zubiaga AM 1995), or more recently in a computational derivation as 
WWWUAUUUAUWWW where W can be either A/U  (Bakheet T 2001). In the IL-8 ARE, 
the second and third AUUUA motifs form the centres of sequences fulfilling these criteria. 
Interestingly, mutants in which both of these AUUUA motifs were destroyed still mediate 
destabilization and stabilization by the p38 MAPK pathway  (Winzen R 2004). Even when the 
individual AUUUA motifs of the IL-8 ARE had been systematically destroyed singly or in 
various combinations  (Winzen R 2004) as long as there was measurable destabilization 
through an ARE, activation of the p38/MK2 pathway induced stabilization. These 
observations thus favor a model in which the p38/MK2 pathway inhibits the destabilization 
exerted by the AREs, perhaps by inactivating or releasing a bound destabilizing ARE-BP (ref 
fig 29). This has been shown for the TNF α mRNA, where activation of the p38/MK2 
pathway phosphorylates the destabilizing ARE-BP, TTP (ref section 2.3.1.1.3)  (Stoecklin G 
2004). The phosphorylation allows the sequestering of TTP by 14-3-3 proteins. Thereby the 
p38/MK2 pathway contributes to the induction in TNF α production in response to LPS 
stimulation. 
 
Since the first observations that implied a role for the p38 MAPK pathway in the regulation of 
the half-lives of a number of AU-rich mRNA including cyclooxygenase 2 (COX2), TNF-α, 
IL-3, IL-6, IL-8, MIP1- α, GM-CSF, VEGF, and uPA  (Brook M 2000),  (Holtmann H 1999),  
(Ming XF 2001),  (Montero L 1999),  (Pages G 2000),  (Stoecklin G 2001), it has been seen 
that not all AREs mediate stabilization through this pathway. A number of mRNAs fulfilling 
the criteria of AREs as defined by the ARED database (ref section 2.3.1) are not stabilized in 
a p38 MAP-kinase dependant manner in response to LPS as an activator of p38/MK2 
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signaling  (Frevel MA 2003),  (Tebo J 2003). There may be several reasons for this. Certain 
AREs may lack features that make them unresponsive to stabilization by p38 MAPK 
activation. It is also possible that this may include not just aspects of the primary sequence but 
also changes involving secondary structure. The presence of additional destabilizing elements 
apart from the AREs may be another reason. This has been shown for the TNF-α mRNA (ref 
fig 28). Its 3’UTR has a special element called the constitutive decay element (CDE) 
downstream of its ARE, which is unresponsive to stabilization by the p38/MK2 pathway  
(Stoecklin G 2003). The CDE can thus destabilize the TNF- α mRNA in an ARE-independent 
and p38/MK2 independent manner. In this study two observation suggest the presence of 
additional destabilizing elements like the CDE: 1) IL-8 mRNA lacking the AU-rich sequences 
exhibit an extended half-life compared to 20mins for an RNA with ARE sequences (fig 9), yet 
appears to exhibit moderate instability (half-life of 2hrs) and 2) the activation of the p38 
MAPK could only extend the half-life of the full length ARE-containing IL-8 mRNA from 
20mins to about 1hr (fig 9 upper panel). Unlike the CDE in the TNF-α mRNA these 
additional destabilizing elements in the IL-8 mRNA, cannot by themselves destabilize leaving 
the IL-8 mRNA still responsive to stabilization by the p38 MAPK pathway (ref fig 28). The 
presence of such elements and their interplay with the AREs would therefore be an important 









































Figure 28: Scheme showing the impact of constitutive destabilizing elements on regulated mRNA 
turnover. Destabilization exerted by the IL-8 and TNF-α AREs can be blocked by activation of the p38/MK2 
pathway. There may exist additional destabilizing elements in the IL-8 3’UTR like the CDE in the TNF-α 
mRNA. These elements are probably not responsive to stabilization by the p38/MK2 pathway. In the case of the 
TNF-α mRNA, the CDE has a strong effect and the net effect on mRNA stability is thus constitutive mRNA 
degradation. For the IL-8 mRNA, evidence suggests that these additional elements exert only a weak effect. 
Hence the net effect would be a predominance of regulated mRNA turnover through the AREs, limited to a small 
extent by the presence of these elements. 
 
5.2 Distinct yet overlapping subsets of AREs can be stabilized by distinct mechanisms of 
mRNA stabilization: In this study, a difference in sequence requirements for stabilization 
through the p38/MK2 pathway as opposed to stabilization due to increased cytoplasmic HuR 
is demonstrated. Gel shift studies in our group indicated that HuR binds to both GMCSF and 
IL-8 AREs  (Winzen R 2004). HuR has been described in literature as a stabilizing ARE-BP 
(ref section 2.3.1.1.1) and recently its cytoplasmic presence has been linked to the p38/MK2-
induced stabilization of ARE transcripts  (Atasoy U 2003),  (Tran H 2003). Hence HuR may 
be involved in the stabilization of IL-8 ARE-containing RNA by the p38/MK2 pathway. The 
results in fig 12A argue against this possibility. While the destabilizing effect of the AUUUA 
motif-containing region of the IL-8 ARE is sensitive to stabilization by the p38/MK2 
pathway, it does not suffice to allow stabilization by HuR. Rather a separate domain from the 
c fos or GMCSF AREs can impose stabilization through HuR as shown for the chimeric ARE 
constructs (fig 12B). The lack of involvement of MK2 in HuR mediated stabilization of the c 
fos AD-IL-8 CD chimeric ARE transcripts also suggests that stabilization by overexpression 
of HuR operates via a mechanism distinct from that used by the p38/MK2 pathway (fig 12C). 
These results thus indicate the existence of subsets of AREs: some like the IL-8 ARE 
apparently sensitive to specific signaling pathways like the p38/MK2 and others like the c fos 
or GMCSF AREs that are responsive to both modes of mRNA stabilization. It is also possible 
that there exists a subset of AREs that are only responsive to stabilization by HuR. 
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As discussed previously the p38/MK2 pathway stabilizes RNA by inhibiting the function of 
destabilizing ARE-BP. The binding to and subsequent stabilization of certain ARE-containing 
RNAs by HuR represents another mechanism of mRNA stabilization, wherein the binding of 
stabilizing ARE-BPs leads to the stabilization of mRNA (ref fig 29). A recent report by Lal et 
al showed that the RNA binding proteins- HuR and AUF1 bind several common target 
transcripts on both distinct, non-overlapping sites and on common sites in a competitive 
fashion  (Lal A 2004). That report complements the displacement model outlined in the 
introduction, whereby decay-promoting and stability-promoting ARE-BPs are thought to 
compete for the same binding site  (Ming XF 2001). So the binding of HuR could alter 
interactions of bound destabilizing ARE-BPs and therefore stabilize certain ARE-containing 
RNA. In the case of the IL-8 ARE, where there is binding to HuR but no stabilization, an as 
yet unidentified destabilizing ARE-BP may compete with the bound HuR. The affinity of 
HuR for the IL-8 ARE may be too low to displace this destabilizing ARE-BP. Alternatively 
HuR may have to bind in a distinct way and/or in combination with certain other proteins to 
stabilize the IL-8 RNA. Irrespective of the reason, the absence of a stabilizing effect of HuR 
on IL-8 ARE-containing mRNA argues against increased levels of HuR in the cytoplasm as 






































Figure 29: Models to explain the structure-function relationship in AREs. AREs appear to have bipartite 
structures with AUUUA-containing core domains and AU-rich or U-rich auxiliary domains. Auxiliary domains 
cannot destabilize on their own but enhance the moderate destabilizing potential of the core domains. (A) 
Stabilization by the p38/MK2 pathway inhibits ARE-dependent rapid mRNA degradation perhaps by affecting 
bound destabilizing ARE-BPs. (B) HuR, a stabilizing ARE-BP requires distinct sequences present in auxiliary 
domains of certain AREs and stabilizes possibly by displacing or affecting in some other way previously bound 
destabilizing ARE-BPs.  
 
 
5.3 Role for the poly (A) tail in regulated ARE-dependent mRNA degradation: The result 
in figure 15 shows that stabilization of an ARE-containing reporter by the p38/MK2 pathway 
is accompanied by inhibition of deadenylation as has been reported recently for COX2 ARE-
containing reporters  (Dean JL 2003). A role for the poly (A) tail in ARE-mediated regulation 
of mRNA stability is supported by the results shown in fig 17, where replacing the poly (A) 
tail with a histone stem loop sequence abolished ARE-dependant regulation of mRNA 
turnover. Additional evidence in support of this hypothesis is provided by the observation that 
the poly (A) binding protein, PABP1, can be phosphorylated in vitro by MK2 the downstream 
substrate of p38  (Bollig F 2003). A physical interaction between an ARE in the 3’UTR of an 
mRNA with PABP1 could disturb the ‘closed loop’ (ref section 2.3, fig 3) structure that forms 
as a result of interactions between PABP1 and the translation initiation factor eIF4G. This 
would then expose the RNA to exonucleases. In support of this model, it has been shown by 
other groups that PABP1 interacts with AU-rich elements  (Wiklund L 2002) with affinity 
constants in the nM range  (Sladic RT 2004). Further support comes from another report, 
which showed using gel mobility shift assays that the ARE of GMCSF interferes with the 
association between PABP1 and the poly (A)-tail  (Grosset C 2004) and interferes with 
translation and mRNA degradation. Hence the p38/MK2 pathway could phosphorylate 
PABP1, alter its association with the AREs thereby causing a stabilization of ARE-containing 




igure 30: Speculative model to explain the role of the poly (A) tail in ARE-dependant regulation of 
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.4 UV light and mRNA stability: Unlike the stabilization mediated by the p38 pathway, 
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mRNA stability. (A) The association of poly (A) binding protein 1 (PABP1) to the poly (A) tail or to eIF4G 
may be impaired in the presence of AREs. This would affect the formation of the closed loop structure 
contributing to the rapid degradation of ARE-containing mRNA. (B) In the presence of the histone stem loop 
PABP1 is replaced by the stem loop binding protein (SLBP). Interactions between the SLBP and eIF4G may b
insensitive to ARE-dependant regulation of mRNA degradation. 
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which appears to be specific to a subset of ARE-containing transcripts, stabilization by UV 
light affects both ARE and non-ARE containing reporter transcripts  (Bollig F 2002) and the
endogenous ARE-containing IL-8 mRNA as has been shown in fig 18 and fig 26 and by 
others in the group  (Beniam 2003). Activation of the p38 MAPK inhibits the rate of 
deadenylation. The effects of UV-B on mRNA deadenylation were therefore examine
figures 18 and 26 show that exposure to UV-B leads to a strong inhibition in the 
deadenylation of both ARE- and non-ARE containing reporters, as well as an inh
deadenylation of the endogenous IL-8 mRNA. To our knowledge this is the first report 
documenting this particular effect of UV light. Since deadenylation is the first step in mR
turnover (ref section 2.2), logic dictates that an inhibition of deadenylation would be the cause
for an inhibition of degradation. However these experiments are insufficient to prove that 
these two effects share a causal relationship. Therefore it is still possible that they are two 
independent effects of UV light that occur in parallel. The significance of an inhibition of 
deadenylation for the mRNA stabilization by exposure to UV light or by the activation of t
p38/MK2 pathway can only be obtained by using additional approaches like examining the 
effects of UV exposure or p38 MAPK activation on known deadenylases. 
 
5
irradiation activates several signal transduction pathways including the p38 MAPK pathw
(ref section 2.4). From our previous studies it was concluded that the activation of the p38 
MAPK pathway alone or in combination with the JNK and NF-κB pathways was not enoug
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to observe UV-B mediated stabilization of the non-ARE reporters  (Bollig F 2002). This 
coincides with observations from Blattner et al who could not prevent UV-C mediated 
stabilization with the use of the SB203580  (Blattner C 2000). We now observe that inh
the activation of p38 MAPK by using the pyridinyl imidazole SB203580 could also not 
inhibit the effect of UV light on mRNA deadenylation (fig 23). The inhibition of mRNA
degradation and deadenylation by UV light could be prevented by high concentrations of 
another protein kinase inhibitor, staurosporine (results not shown), suggesting that the effe
of UV light involves a phosphorylation event.  But at lower concentrations where specificity 
towards certain kinases like PKC is expected  (Matsumoto K 1998), (check staurosporine 




www.biocompare.com), the effect of UV light on mRNA degradatio
and deadenylation could not be inhibited. Moreover we and others have tested various other 
protein kinase inhibitors but could not prevent UV-induced mRNA stabilization (data not 
shown) and  (Blattner C 2000). These observations suggest that the effect of UV-B on mR
degradation and deadenylation may involve an as yet unidentified signalling pathway or a 














source of the signalling that is needed to observe UV-induced mRNA stabilization. In 
addition to events triggered by DNA damage, it has become quite evident that there exi
other, non-nuclear sources for the signalling (ref section 2.4),  (Bender K 1997). The resul
fig 20 indicate that signalling initiated by γ-radiation induced DNA damage is not sufficient to 
inhibit mRNA degradation and deadenylation. But this does not exclude that signals initiated 
by the specific type of UV-induced DNA damage are involved in the effect of UV light on 
mRNA stabilization. Apart from UV light, other stresses like heat shock and ER stress have
been reported to have global effects on mRNA turnover  (Fan J 2002),  (Kawai T 2004). The
results in fig 19 show that heat shock at 44ºC and osmotic stress impair the degradation and 
deadenylation of ARE- and non-ARE containing reporters. As heat shock is not associated 
with DNA damage, this supports the notion that the inhibition of mRNA degradation and 
deadenylation by UV light may not be a general consequence of DNA damage. On the oth
hand exposure to H2O2 led to an inhibition of mRNA deadenylation and degradation in a 
manner similar to that of UV light (fig 20). It has been suggested that reactive oxygen spe
(ROS) may be key regulators of UV-induced signalling pathways (ref section 2.4). But the 
results in figures 21 and 22 indicate that inhibiting signalling initiated by free radicals with t
antioxidants, N-acetyl cysteine (NAC) and butylated hydroxy anisole (BHA) or the 
expression of human catalase could not inhibit the effects of UV light on mRNA stab
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was also examined if UV light exerts its effects on mRNA stability by a direct modification o
the RNA molecules as it has been reported that UV light can cause site-specific damage of the 
28s rRNA  (Iordanov MS 1998). But as was shown in figure 26, the effects of UV light on 
mRNA degradation and deadenylation were reproducible on endogenous IL-8 RNA that wa
generated after exposure to UV light. This study thus rules out direct modification of RNA 
molecules or the involvement of ROS in the UV-mediated inhibition of mRNA degradation 
and deadenylation, but has helped identify a group of cellular stresses apart from UV light-




igure 31: Scheme showing the possible sources of signalling for the effect of UV light on mRNA 






2O2 that have similar effects on mRNA degradation an



























DNA damage or a direct modification of the RNA molecules. Nor is it dependant on ROS. Stresses like U
and H2O2 , all of which lead to an inhibition of mRNA degradation may activate a common signalling pathway
or may activate distinct signalling events that end in the same effect on mRNA stability.  
 
5.6 Physiological relevance of UV-B mediated mRNA stabilization: The
between mRNA degradation and translation has always been a point of contention among
scientists. Studies by Kedersha et al showed that several environmental stresses lead to the 
accumulation of untranslated RNA in cytoplasmic foci termed stress granules as a 
consequence of the translational shut down that accompanies exposure to environm
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stresses (ref section 2.4)  (Kedersha N 2002),  (Kedersha N 2000). But there are contradic
reports as to the fate of the mRNA in these granules. While the group of Paul Anderson 
suggest that stress granules are closely related to mRNA turnover  (Stoecklin G 2004), ot
have shown that factors involved in mRNA degradation and deadenylation accumulate in foci 
distinct from the stress granules  (Cougot N 2004). Additional results (results not shown) 
showed that expressing the transdominant inhibitors of stress granule formation, TIA1∆RR
and TIAR∆RRM  (Kedersha NL 1999), did not affect UV-dependant mRNA stabilization. 














synthesis which effect presumably requires phosporylation of the translation initiation 
eIF2α. eIF2α was shown to be phosphorylated by both UV-C and UV-B  (Wu S 2002),  (Deng
J 2002),  (Jiang HY 2004). Results in fig 24 show that the effects of UV-B on mRNA 
degradation and deadenylation occur with the same dose response relation, which falls
the range of the minimal erythemic doses of UV-B light in man. The inhibition of translation 
on the other hand required higher doses of UV light  (Beniam 2003). This thus explains why 
prolonged stabilization of the endogenous IL-8 mRNA (ref fig 26) is accompanied by 
increased protein synthesis  (Beniam 2003).  
 
S
cells to compensate for the general decrease in RNA synthesis that occurs in response to UV 
exposure  (Rockx DA 2000). This involves phosphorylation of the C-terminal domain of RNA
polymerase II and its subsequent proteasome dependant degradation  (Rockx DA 2000),  
(Kuznetsova AV 2003),  (Lee KB 2002). UV-light can stabilize several short-lived transcr
(ref section 2.4)  (Bollig F 2002),  (Blattner C 2000),  (Wang W 2000). A common feature of 
the mRNAs of genes involved in the inflammatory response is their short half-lives. Hence a 
stabilization of these mRNA by UV light could well be crucial for controlling the extent and 
duration of gene expression during the inflammatory response. The results with the IL-8 
mRNA (fig 26) and the microarray results where there appears to be a stabilization of a gr
of transcripts including IL-6, Cxcr4 and jun (ref table 2) support this hypothesis. Further 
studies need to be done with primary keratinocytes to confirm the role of UV-dependant 






5.7 PERSPECTIVES:  











stabilization induced by activation of the p38/MK2 pathway, by increased expression of 
and by exposure to UV-B, all of which have been suggested to be inter-related. What has 
emerged is the diversity in the requirements for each mode of stabilization. While the 
p38/MK2 pathway is specific to a certain group of AREs some of which have bipartite
structures, stabilization by overexpression of HuR requires distinct domains that are pre
the c fos and GMCSF AREs and absent in the IL-8 ARE, thus defining distinct subsets of 
AREs. The structural and functional importance of these domains for different AREs need
be examined in future studies. UV-induced stabilization on the other hand does not require the 
presence of AREs. Both the activation of the p38/MK2 pathway and exposure to UV light 
lead to an inhibition of mRNA deadenylation, while the overexpression of HuR as seen in o
studies and reported earlier has if at all only a marginal effect on deadenylation. More direct 
evidence in the form of effects on currently known deadenylases needs to be looked at to 
confirm these differences. The downstream effector of the p38/MK2 pathway responsible 
mediating the inhibition of degradation has remained elusive to this date although some 
evidence has been presented by Stoecklin et al  (Stoecklin G 2004). Likewise the signalli
events downstream of exposure to UV-B that lead to mRNA stabilization remain unknown. 
Hence although with the help of this study some answers have been obtained, more question


























































examined in this study. p38/MK2-dependant mRNA stabilization is specific to ARE-containing RNA, some
which have bipartite structures-with auxiliary and core domains and appears to inhibit the rate of mRNA 
deadenylation. HuR-dependant stabilization affects a distinct but overlapping subset of AREs and appears to act 
through the presence of auxiliary domains in these AREs. Here the stabilization appears to have no or minimal 
effects on deadenylation. Direct cellular stresses like UV light and heat shock through an as yet unidentified 
pathway lead to a stabilization of both ARE and non ARE-containing RNA. This stabilization is accompanied by
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7  ABBREVIATIONS 
 
%    Percent 
α    alpha 
β    beta 
A    Adenine 
ARE    AU-rich element 
ARE-BP   ARE-binding protein 
bp    base pairs 
˚C    degrees celsius 
cDNA    complementary DNA 
cm2    squared centimeter 
CSPD    chemiluminescent substrate 
DEAE    Diethylaminoethyl 
dH2O    distilled water 
ddH2O    double distilled water  
DNA     deoxyribonucleic acid 
DIG    Digoxygenin 
DNase    deoxyribonuclease 
dNTPs    deoxyribonucleoside triphosphate mix 
DTT    Dithiothreitol 
EtBr    Ethidium Bromide 
E.coli    Escherichia coli 
EDTA    Ethylenediaminetetracetic acid 
eIF    eukaryotic initiation factor 
ERK    extracellular signal-regulated kinase 
et al    and others 
FCS    fetal calf serum 
Fig    figure 
g    gram 
g/l    gram per liter 
GAPDH   Glyceraldehyde-3-phosphate dehydrogenase 
GMCSF   granulocyte/macrophage colony stimulating factor 
HEPES   N-2-Hydroxyethylpiperazine-N’-2-ethanesulphonic acid 
HEBS    Hepes buffered saline 
h/hrs    hours 
IL    interleukin 
JNK    c jun N-terminal kinase 
Kb    kilobase (pair) 
kDA    kilodalton 
LB    luria-bertoni 
LPS    lipopolysaccharide 
µ    micro (10-6)  
m     milli (10-3) 
M    molar 
mA    milliampere 
mM    millimolar 
MAPK    mitogen activated protein kinase 
MEKK   MAPK/ERK kinase kinase 
mg    milligram 
 96
min/s    minute/s 
MKK    MAP kinase kinase 
ml    milliliter 
mol    Mole (6.023 x 1023 molecules) 
MMLV   mouse mammary leukemia virus 
mRNA    messenger RNA 
NaCl    Natrium chloride 
nm    nanometre 
nt    nucleotide 
OD    optical density 
O/N    overnight 
PAGE    polyacrylamide gel electrophoresis 
PABP1   poly (A) binding protein 1 
PBS    phosphate buffered saline 
PCR    polymerase chain reaction 
pmoles    picomoles (10-12 moles) 
RCF (g)   relative centrifugation force 
ref    refer to 
RNA    ribonucleic acid 
RNase    ribonuclease 
ROS    Reactive oxygen species 
rpm    revolutions per minute 
RRM    RNA recognition motifs 
RT    reverse transcription/room temperature 
secs    seconds 
SAPK    stress activated protein kinase 
SDS    Sodium dodecyl sulphate 
TAE    Tris-Acetate-EDTA 
TBE    Tris-Borate-EDTA 
TEMED   N, N, N’, N’- tetramethlenediamine 
TIMP    tissue inhibitor of matrix metallo-protease 
TNF    tumour necrosis factor 
Tris    Tris (hydroxymethyl)-aminoethane 
U    units 
UTR    untranslated region 
UV    ultraviolet light 
V    volt 
v/v    volume by volume 
w/v    weight by volume 
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